TSS:Rfhg 189142.1

Basic information about the TSS

---

TSS ID: rfhg_189142.1 Species: human Chr: chr17		Start: 7308338 End: 7308379 Strand: +
Source datasets	FANTOM5|EPD
Protocol	CAGE|TSS_database
TSS cluster detected*	2

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	PLS,CTCF-bound (EH38D2905743,EH38E1844245)
Category:	PLS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000416016.2:0 GeneID: 1984 HGNC/MGI_ID: HGNC:3300 UniProt_ID: P63241 Nearer transcript ids and distances:

Gene_name: EIF5A Gene_symbol: EIF5A Gene_synonyms: EIF-5A EIF5A1 MGC104255 MGC99547 Gene_source: HGNC:3300

TATA-Box annotation

---

Distance to TSS:	-17
Nearest PromoterID:	NM_001143762
Entrez ID:	1984
Nearest Unigene:	Hs.534314
Nearest Refseq:	NM_001970
Nearest Ensembl:	ENSG00000132507
Gene Name:	EIF5A
Gene Alias:	EIF-5A|EIF5A1|eIF5AI
Gene Type:	protein-coding
CpG%:	0.097561
GC%:	0.738095
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@EIF5A p2@EIF5A p3@EIF5A p4@EIF5A p5@EIF5A p6@EIF5A p7@EIF5A p8@EIF5A p9@EIF5A
Sample		p1@EIF5A	p2@EIF5A	p3@EIF5A	p4@EIF5A	p5@EIF5A	p6@EIF5A	p7@EIF5A	p8@EIF5A	p9@EIF5A
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	857.52	241.95	11.10	75.39	11.10	17.14	1.95	4.68	0.00
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	902.95	227.00	9.91	72.43	13.56	16.19	1.62	4.86	0.00
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	899.13	210.27	7.91	70.99	13.70	16.40	3.28	4.63	0.00
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	758.04	199.39	8.32	62.17	9.98	19.13	1.25	3.95	0.00
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	880.97	229.69	10.12	73.56	8.77	19.12	2.92	5.85	0.67
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	822.73	197.88	8.92	65.31	9.69	21.32	2.52	5.04	0.39
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	868.27	248.82	7.41	80.83	17.87	22.88	3.49	9.37	0.00
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	839.53	260.14	7.51	96.40	15.74	23.98	3.88	6.30	0.48
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	832.21	264.37	7.69	93.82	15.39	27.36	2.35	7.27	0.21
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	531.52	137.95	9.85	59.70	11.01	35.94	1.16	7.54	0.00
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	512.16	145.12	4.04	55.78	10.11	28.70	1.21	6.87	0.81
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	445.18	138.23	6.10	51.23	7.32	37.00	1.22	5.29	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	208.10	10.96	31.59	3.06	1.29	0.48	0.48	0.32	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	210.04	12.18	31.72	4.21	1.35	0.60	0.45	0.15	0.75
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	185.96	10.76	26.57	2.63	0.88	0.88	1.10	0.44	1.10
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	188.37	10.06	29.17	2.01	0.75	0.00	0.50	0.75	0.75
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	189.80	8.52	26.86	3.49	0.66	0.22	0.66	0.00	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	172.10	10.55	19.83	2.53	0.00	0.00	0.42	0.42	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	160.48	5.86	17.06	3.73	0.00	1.60	0.00	0.00	0.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	162.33	10.38	24.52	2.26	0.45	0.60	0.45	0.30	0.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	214.24	10.56	26.20	2.41	1.60	0.53	0.94	0.80	0.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	194.55	12.60	24.69	3.63	1.55	0.17	0.52	1.04	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	204.87	13.83	27.66	3.62	1.03	0.13	0.65	0.90	0.39
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	204.57	13.10	29.36	3.40	0.73	0.73	0.49	0.73	0.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	183.69	10.58	29.15	3.61	0.26	0.77	0.77	0.52	1.03
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	197.19	8.55	25.32	4.43	1.90	0.00	0.63	0.63	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	158.79	11.54	20.88	2.20	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	228.44	14.62	31.83	2.83	1.89	0.47	0.47	0.00	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	167.98	13.24	28.91	1.62	1.13	0.00	0.32	0.16	0.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	201.23	13.39	35.29	2.90	1.99	1.27	0.18	0.54	0.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	186.94	15.07	28.05	2.72	0.21	0.00	0.21	0.84	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	169.59	11.53	26.57	2.15	0.39	0.39	0.20	0.78	0.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	199.63	10.34	23.64	2.53	0.42	1.27	0.21	0.42	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	209.31	15.34	28.37	1.48	1.48	0.66	0.33	0.82	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	193.72	14.96	29.17	2.99	0.56	0.56	0.37	0.56	0.75
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	202.74	14.56	30.66	2.68	1.34	0.57	0.19	0.77	0.57
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	230.13	14.92	34.34	3.68	1.43	0.20	0.61	0.82	0.82
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	227.48	16.12	35.86	2.62	1.61	0.60	0.40	1.01	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	232.83	14.05	28.90	4.59	0.27	0.00	0.00	0.00	0.54
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	212.69	15.84	28.81	2.88	0.72	1.20	0.96	0.72	0.96
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	229.14	14.35	35.29	3.76	0.24	0.71	0.71	0.71	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	226.76	19.47	31.62	3.51	1.61	1.17	0.59	0.88	0.73
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	185.59	12.86	30.79	1.69	0.84	0.00	0.42	0.84	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	203.85	15.38	31.64	3.50	0.52	0.35	0.17	0.87	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	225.27	13.85	30.12	3.01	1.00	0.60	0.80	0.40	0.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	210.31	15.59	27.68	2.33	1.86	0.70	0.23	0.93	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	205.60	13.91	31.67	3.84	0.48	0.72	0.24	0.72	1.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	191.05	15.20	28.02	2.09	0.89	0.60	0.30	0.60	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	204.90	14.12	26.81	3.11	1.44	1.20	1.20	1.20	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	191.08	13.95	27.90	4.25	0.81	0.40	0.61	0.81	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	191.63	14.76	26.85	1.84	0.20	0.41	0.61	0.20	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	187.68	19.57	30.91	2.89	0.44	1.33	0.44	0.67	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	475.73	69.96	41.98	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	185.95	10.65	28.03	2.84	0.00	1.77	0.00	0.71	1.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	186.90	17.56	30.16	3.31	0.00	0.00	0.33	0.33	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	250.00	27.68	18.46	5.03	0.00	1.68	2.52	0.84	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	252.12	18.37	26.64	1.84	0.46	2.30	0.92	1.38	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	135.15	14.26	35.65	1.62	0.97	0.65	0.65	0.97	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	129.11	9.96	33.08	3.53	0.96	0.96	0.64	0.32	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	233.55	20.75	31.75	3.77	0.63	0.31	1.57	0.63	0.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	181.20	16.22	37.37	2.82	0.00	0.00	0.00	0.00	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	197.96	17.38	37.57	6.17	0.56	0.56	0.56	1.68	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	317.66	32.64	27.07	3.98	2.39	0.80	0.00	1.59	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	233.08	20.73	28.20	3.74	0.68	1.70	0.34	0.68	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	167.01	9.10	29.89	2.27	0.00	1.30	0.00	1.30	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	165.78	16.33	39.40	2.48	1.06	0.00	0.71	1.06	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	678.89	96.98	32.33	0.00	0.00	0.00	16.16	48.49	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	718.67	102.67	78.97	7.90	7.90	0.00	0.00	7.90	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	223.28	22.91	43.88	4.39	0.49	0.00	0.49	0.98	0.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	260.33	29.26	48.60	4.46	0.50	2.48	0.00	0.00	0.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	235.50	27.21	36.59	6.10	0.00	0.47	0.00	0.00	1.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	256.67	30.80	51.00	4.31	0.33	0.66	0.00	2.32	0.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	165.81	21.34	51.97	3.40	0.31	0.62	0.00	1.24	1.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	195.37	27.82	62.37	3.67	0.61	0.61	0.31	1.22	1.22
Adipocyte - breast, donor1	11376-118A8	371.57	46.09	47.99	9.34	0.79	0.95	0.79	0.16	0.63
Adipocyte - breast, donor2	11327-117E4	342.83	60.00	39.79	12.19	4.65	0.80	0.80	0.64	0.16
Adipocyte - omental, donor1	11473-119C6	361.45	38.04	43.38	7.63	1.53	1.40	0.89	0.51	0.76
Adipocyte - omental, donor2	11474-119C7	369.26	47.84	68.02	2.99	5.23	2.99	0.75	1.49	2.24
Adipocyte - omental, donor3	11475-119C8	319.85	30.14	44.54	5.69	3.35	0.00	1.67	1.00	0.67
Adipocyte - perirenal, donor1	11476-119C9	385.98	28.07	54.23	8.29	1.28	0.64	0.64	0.00	0.64
Adipocyte - subcutaneous, donor1	11259-116F8	294.67	38.48	43.98	7.70	5.50	0.00	0.00	1.10	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	669.76	151.75	59.16	23.48	3.16	1.81	0.90	0.45	0.90
Adipocyte - subcutaneous, donor3	11408-118E4	363.37	58.56	59.61	7.47	3.30	1.91	1.22	0.70	1.04
Adipocyte differentiation, day04, donor1	13019-139D4	438.86	68.65	53.39	9.58	4.89	0.98	1.17	0.78	1.56
Adipocyte differentiation, day04, donor2	13022-139D7	286.98	28.31	28.57	6.18	1.29	1.54	1.03	0.51	0.00
Adipocyte differentiation, day04, donor3	13025-139E1	370.49	50.46	28.71	10.87	3.62	2.51	0.28	0.28	0.84
Adipocyte differentiation, day04, donor4	13028-139E4	279.80	25.86	31.15	8.82	0.59	0.59	0.00	0.00	0.59
Adipocyte differentiation, day08, donor1	13020-139D5	436.27	70.22	53.33	12.71	10.62	1.29	0.72	0.48	0.80
Adipocyte differentiation, day08, donor2	13023-139D8	226.57	27.11	33.57	4.52	0.65	1.61	0.97	0.65	1.29
Adipocyte differentiation, day08, donor3	13026-139E2	198.88	17.60	15.46	4.80	3.73	0.00	1.07	0.00	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	277.11	27.27	25.60	6.12	1.67	1.11	0.56	0.56	1.67
Adipocyte differentiation, day12, donor1	13021-139D6	361.41	45.75	39.51	14.56	2.50	0.83	0.83	0.00	1.25
Adipocyte differentiation, day12, donor2	13024-139D9	246.64	29.14	23.61	5.27	2.76	1.26	0.50	0.50	0.25
Adipocyte differentiation, day12, donor3	13027-139E3	254.60	34.69	25.85	8.84	2.29	1.31	0.98	0.33	0.65
Adipocyte differentiation, day12, donor4	13030-139E6	193.03	23.75	19.79	3.96	2.74	0.61	0.30	0.00	0.61
Alveolar Epithelial Cells, donor1	11510-119G7	890.18	190.06	78.23	62.32	16.35	0.44	0.66	3.54	1.99
Alveolar Epithelial Cells, donor2	11590-120G6	1325.68	260.69	166.02	62.39	47.69	2.87	0.36	5.02	6.10
Alveolar Epithelial Cells, donor3	11671-122G6	510.35	67.09	46.72	14.38	7.19	1.20	0.00	0.00	1.20
Amniotic Epithelial Cells, donor1	11533-120A3	476.93	47.85	47.32	12.59	3.24	1.08	1.80	0.72	0.54
Amniotic Epithelial Cells, donor2	11613-122A2	403.31	15.06	28.45	5.02	3.35	0.00	1.67	1.67	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	413.15	48.69	45.20	9.04	1.85	0.82	0.41	0.41	1.64
Anulus Pulposus Cell, donor1	11248-116E6	378.06	27.81	35.36	7.21	0.69	1.60	2.86	0.69	0.57
Anulus Pulposus Cell, donor2	11463-119B5	293.40	19.35	46.53	4.65	1.47	0.24	3.18	0.73	0.98
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	425.48	60.21	48.07	9.44	2.70	0.00	0.90	0.45	2.70
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	466.27	57.31	67.73	15.19	3.47	0.43	0.87	1.30	4.34
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	434.47	40.66	44.95	17.12	0.00	2.14	2.14	2.14	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	411.91	48.72	51.12	10.16	3.29	0.60	2.69	1.79	1.49
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	566.56	63.23	84.73	13.91	1.26	0.00	1.26	2.53	2.53
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	398.02	40.92	39.60	5.28	0.66	0.66	0.00	1.32	0.66
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	410.33	50.68	56.86	10.07	1.95	0.65	0.65	1.30	1.62
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	474.76	55.83	62.62	13.11	3.88	0.49	0.97	1.46	4.85
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	412.75	48.10	51.67	13.66	0.59	0.00	1.19	1.78	1.78
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	460.25	58.76	59.13	10.17	4.14	0.00	2.26	1.13	1.88
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	443.39	64.58	61.68	13.79	2.90	0.73	0.00	2.18	5.08
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	471.42	41.37	62.69	17.55	0.00	0.00	0.00	1.25	1.25
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	581.19	69.68	76.77	17.96	1.65	0.99	0.66	1.98	1.65
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	484.50	47.77	53.23	17.74	2.73	1.36	0.00	0.00	1.36
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	414.07	50.21	58.96	14.17	1.51	1.66	0.60	1.81	1.06
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	445.77	57.86	52.51	11.25	3.75	0.00	0.54	2.14	1.07
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	450.23	58.57	61.97	12.85	3.02	0.19	0.76	1.13	2.46
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	471.23	49.18	53.46	15.50	2.14	0.80	1.07	0.27	2.67
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	421.40	35.12	53.65	14.63	0.98	0.98	0.00	0.98	0.98
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	433.06	62.03	70.66	11.61	3.32	0.33	0.50	1.33	1.33
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	487.49	50.43	42.03	16.81	2.40	0.00	1.20	1.20	2.40
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	474.38	28.32	77.88	21.24	0.00	0.00	7.08	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	418.53	57.98	68.96	12.35	4.97	1.03	0.51	1.20	1.54
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	432.08	33.56	46.14	8.39	0.00	0.00	4.19	0.00	4.19
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	448.05	47.57	50.00	13.11	5.34	0.00	1.46	2.91	3.40
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	485.32	62.23	70.58	12.90	4.93	0.38	3.04	2.66	1.52
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	397.33	42.40	48.45	9.69	1.21	0.00	1.21	2.42	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	449.76	58.14	53.01	11.97	3.99	1.71	2.28	0.00	2.28
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	440.80	59.22	72.90	9.62	4.06	0.43	1.50	1.28	1.50
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	388.68	43.62	47.49	12.39	0.77	0.26	0.52	2.06	1.81
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	461.23	62.87	59.12	14.55	0.94	0.94	0.00	1.41	1.88
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	463.67	63.67	69.45	13.51	3.86	0.96	0.32	2.89	1.93
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	433.07	56.36	52.80	22.83	1.43	1.43	0.00	1.43	2.14
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	455.68	59.08	71.36	8.19	1.75	0.58	1.75	1.17	1.17
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	448.00	58.11	65.93	12.65	3.91	1.51	2.11	0.90	2.41
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	476.38	46.33	67.72	19.01	1.19	0.00	0.00	0.00	1.19
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	551.79	53.91	68.66	18.82	3.56	0.51	1.02	1.53	2.54
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	470.15	60.87	70.80	18.59	4.33	0.25	0.51	2.80	1.53
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	421.88	56.55	57.18	10.17	1.91	0.64	0.64	1.27	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	460.45	51.78	65.59	14.67	3.88	0.43	0.86	1.73	0.86
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	423.37	58.00	63.51	11.85	3.81	0.64	0.85	1.06	1.91
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	390.32	39.44	53.07	11.89	1.74	0.58	0.00	0.87	0.58
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	514.88	55.74	63.30	8.50	1.89	1.89	1.89	0.94	0.94
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	437.03	52.72	66.62	11.19	5.26	0.51	0.17	1.36	2.37
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	403.05	30.11	48.64	18.53	0.00	0.00	0.00	0.00	2.32
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	485.89	31.69	61.26	25.35	0.00	2.11	0.00	2.11	2.11
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	443.62	55.75	61.97	12.86	2.79	1.07	0.86	1.07	1.07
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	458.47	40.91	52.95	13.84	0.00	0.60	0.60	1.80	1.80
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	473.11	51.76	59.05	11.66	5.10	0.00	0.73	0.73	4.37
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	501.83	64.14	71.26	11.26	5.06	1.38	0.92	1.61	1.38
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	428.45	35.70	51.01	10.20	0.00	0.00	0.00	5.10	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	497.78	55.42	61.52	18.05	1.27	1.53	0.00	1.78	1.02
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	495.04	62.34	69.57	10.53	5.37	0.83	1.65	1.45	1.65
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	409.43	48.96	47.12	12.55	0.31	1.22	0.00	2.45	1.53
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	463.19	62.14	70.75	10.99	6.21	0.48	1.43	2.39	0.96
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	441.93	59.65	67.63	10.87	3.10	0.67	0.22	1.33	2.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	444.01	53.40	59.51	9.15	0.00	1.53	0.00	1.53	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	461.39	55.94	63.70	11.63	1.11	0.00	1.11	1.66	1.11
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	418.64	50.31	56.93	12.71	1.59	1.06	0.26	1.59	0.26
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	392.89	46.16	53.43	14.90	2.18	0.36	0.36	0.73	2.18
Astrocyte - cerebellum, donor1	11500-119F6	1087.05	79.46	70.25	25.55	7.12	2.21	3.44	2.95	2.21
Astrocyte - cerebellum, donor2	11580-120F5	848.44	72.06	84.21	19.85	10.44	1.88	3.94	1.88	2.57
Astrocyte - cerebellum, donor3	11661-122F5	518.29	32.30	26.43	8.39	2.31	1.89	2.94	1.26	0.84
Astrocyte - cerebral cortex, donor1	11235-116D2	379.26	31.02	28.93	8.37	2.44	2.44	2.44	0.35	1.39
Astrocyte - cerebral cortex, donor2	11316-117D2	602.61	93.02	39.80	26.37	10.68	3.56	1.62	1.62	0.97
Astrocyte - cerebral cortex, donor3	11392-118C6	459.26	47.58	28.34	11.63	6.26	1.79	3.28	1.34	0.60
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	725.50	104.59	49.66	21.68	16.86	4.93	8.14	5.05	1.49
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	818.22	125.91	56.38	25.68	19.54	7.77	7.02	7.89	0.88
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	738.31	105.03	40.40	28.68	15.36	5.23	6.49	5.69	0.80
Basophils, donor1	12241-129G9	336.59	29.55	12.82	5.75	3.14	5.23	7.32	0.78	0.00
Basophils, donor2	12242-129H1	314.97	18.40	19.12	5.41	2.89	5.41	2.16	0.00	0.36
Basophils, donor3	12243-129H2	338.83	31.90	31.46	3.97	3.38	7.64	6.61	0.29	0.15
Bronchial Epithelial Cell, donor1	11511-119G8	476.91	117.93	114.70	39.24	9.92	0.86	0.43	1.08	4.31
Bronchial Epithelial Cell, donor2	11591-120G7	835.74	197.05	167.33	43.89	21.03	1.37	0.91	1.37	4.11
Bronchial Epithelial Cell, donor3	11672-122G7	351.50	78.91	114.78	57.39	7.17	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	545.43	191.43	101.05	54.61	27.62	0.63	0.00	5.02	4.39
Bronchial Epithelial Cell, donor5	11457-119A8	655.88	195.89	129.97	60.31	35.98	0.83	0.21	2.91	3.95
Bronchial Epithelial Cell, donor6	11461-119B3	479.23	126.66	98.10	37.08	15.20	0.23	0.23	2.53	3.68
Bronchial Epithelial Cell, donor7	11769-123I5	327.86	85.29	74.68	21.77	13.68	0.72	0.18	1.26	1.08
Burkitt's lymphoma cell line:DAUDI	10422-106C8	670.99	78.12	58.12	19.37	9.89	21.02	8.76	8.66	2.89
Burkitt's lymphoma cell line:RAJI	10476-106I8	481.88	116.92	44.95	49.38	36.33	7.92	5.36	6.06	0.47
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	586.79	55.64	73.23	19.19	3.52	11.83	14.39	1.60	0.96
CD133+ stem cells - cord blood derived, pool1	12223-129E9	1054.88	82.74	72.39	10.34	10.34	62.05	10.34	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	321.23	26.49	29.30	1.13	1.13	2.82	3.94	0.00	0.56
CD14+ Monocytes, donor2	11305-117B9	273.95	21.34	27.10	3.71	1.86	2.97	2.41	0.19	0.19
CD14+ Monocytes, donor3	11381-118B4	299.23	22.61	23.71	3.07	2.41	3.95	3.73	0.22	0.44
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	180.87	13.30	10.19	1.42	0.28	4.25	5.66	0.00	0.28
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	192.57	14.78	14.03	2.27	1.52	4.55	3.03	0.00	0.00
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	188.04	14.14	9.20	2.30	0.33	2.30	3.29	0.00	0.00
CD14+ monocytes - mock treated, donor1	11863-125A9	143.83	10.41	9.97	1.45	0.72	2.89	1.73	0.14	0.00
CD14+ monocytes - mock treated, donor2	11873-125C1	125.83	8.45	11.47	1.21	0.30	3.02	1.51	0.00	0.00
CD14+ monocytes - mock treated, donor3	11883-125D2	161.80	9.00	14.45	1.66	1.18	2.61	2.61	0.00	0.00
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	133.58	8.04	9.37	1.51	0.50	1.51	1.17	0.00	0.33
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	129.17	15.46	10.76	1.93	0.28	1.66	1.10	0.28	0.00
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	184.95	14.88	16.61	2.48	1.24	2.73	0.99	0.00	0.00
CD14+ monocytes - treated with BCG, donor1	11860-125A6	152.53	9.79	9.79	1.76	0.59	3.52	2.15	0.00	0.00
CD14+ monocytes - treated with BCG, donor2	11870-125B7	120.36	10.50	10.86	1.07	0.53	2.31	1.96	0.00	0.00
CD14+ monocytes - treated with BCG, donor3	11880-125C8	282.05	25.25	19.37	2.83	1.31	3.92	2.39	0.22	0.22
CD14+ monocytes - treated with Candida, donor1	11868-125B5	136.03	11.94	5.85	2.34	0.70	1.87	2.11	0.00	0.00
CD14+ monocytes - treated with Candida, donor2	11878-125C6	158.94	17.42	10.03	0.00	0.00	0.53	1.58	0.00	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	239.62	23.30	15.53	2.22	2.22	4.44	1.11	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	156.63	8.92	10.71	2.38	0.89	2.23	2.53	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	135.49	10.18	9.78	1.20	0.60	2.79	1.60	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	222.56	18.95	14.57	3.12	0.42	6.04	4.16	0.21	0.42
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	179.37	12.58	9.15	2.06	0.92	2.29	2.29	0.23	0.23
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	146.35	9.50	8.60	2.71	0.90	1.81	1.58	0.00	0.23
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	171.97	13.97	6.98	1.75	0.00	4.36	2.18	0.00	0.44
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	125.89	6.99	8.34	0.81	0.27	1.34	2.42	0.27	0.27
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	137.82	7.85	14.31	1.40	0.87	2.44	1.92	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	192.32	11.36	16.83	1.26	0.00	3.79	0.84	0.00	0.42
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	187.20	24.62	8.08	2.39	1.47	2.76	2.39	0.00	0.37
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	166.97	11.98	10.22	0.35	0.70	2.47	1.41	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	202.25	32.47	12.28	3.07	1.75	1.32	2.63	0.00	0.88
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	144.03	9.94	10.81	1.74	0.52	1.57	0.87	0.00	0.17
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	162.79	11.52	13.38	1.49	0.00	3.35	2.97	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	268.14	21.12	21.99	3.02	1.08	5.60	4.53	0.00	0.43
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	220.71	19.25	12.28	3.28	0.41	1.64	0.41	0.41	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	176.86	19.47	11.13	4.40	1.62	1.85	2.55	0.23	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	256.82	38.28	13.46	4.18	1.39	3.48	1.39	0.23	0.00
CD14+CD16+ Monocytes, donor1	11789-124B7	393.42	32.48	39.45	5.89	1.09	16.35	8.50	0.22	0.44
CD14+CD16+ Monocytes, donor2	11801-124D1	400.54	36.04	34.19	7.16	0.69	12.01	7.16	0.23	0.23
CD14+CD16+ Monocytes, donor3	11912-125G4	445.36	43.32	43.97	7.58	1.30	17.11	6.50	0.22	0.43
CD14+CD16- Monocytes, donor1	11788-124B6	367.35	23.83	31.92	5.76	1.71	8.72	7.63	0.16	0.16
CD14+CD16- Monocytes, donor2	11799-124C8	333.57	23.58	24.10	6.11	0.70	8.91	6.81	0.00	0.00
CD14+CD16- Monocytes, donor3	11910-125G2	313.05	19.18	24.53	4.24	1.34	8.47	3.79	0.00	0.00
CD14-CD16+ Monocytes, donor1	11790-124B8	327.90	35.21	22.71	6.38	0.77	14.03	7.91	0.00	0.00
CD14-CD16+ Monocytes, donor2	11800-124C9	318.15	30.30	13.83	3.73	0.66	11.42	5.71	0.00	0.22
CD14-CD16+ Monocytes, donor3	11911-125G3	383.61	27.16	30.32	5.05	1.47	18.74	8.84	0.00	0.21
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	367.85	22.36	34.55	8.13	0.00	18.29	14.23	2.03	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	399.33	32.54	40.00	3.39	3.39	22.37	14.92	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	353.14	32.10	39.35	6.21	1.04	18.64	9.32	1.04	1.04
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	347.54	33.58	34.11	5.86	2.13	20.26	15.99	1.07	0.53
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	379.00	32.16	41.81	2.14	1.07	28.95	20.37	0.54	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	363.60	18.25	37.90	2.11	2.11	27.38	12.63	0.70	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	385.90	29.02	36.08	5.49	4.71	29.02	14.90	1.57	1.57
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	420.53	38.23	47.46	5.27	7.91	29.00	22.41	1.32	0.00
CD19+ B Cells, donor1	11544-120B5	332.87	32.05	31.23	1.64	0.82	23.01	9.04	0.00	0.00
CD19+ B Cells, donor2	11624-122B4	370.69	29.74	42.07	3.63	1.45	14.51	5.80	0.00	0.00
CD19+ B Cells, donor3	11705-123B4	314.51	25.75	38.37	5.55	3.03	15.14	5.05	1.01	0.50
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	806.90	77.98	78.39	31.11	8.49	4.85	2.83	0.00	3.23
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	765.82	75.10	89.89	36.35	7.19	2.40	0.80	0.00	1.20
CD34+ Progenitors, donor1	11545-120B6	267.08	14.06	14.06	4.02	0.00	3.01	7.03	0.00	0.00
CD34+ Progenitors, donor2	11625-122B5	464.62	32.58	38.76	4.49	4.49	4.49	6.18	0.00	0.56
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	647.80	64.25	87.55	16.53	12.02	15.03	15.03	2.63	1.88
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	624.81	59.30	84.11	18.94	8.12	14.66	13.98	3.38	0.68
CD4+ T Cells, donor1	11225-116C1	439.18	24.99	38.92	6.43	3.21	4.64	2.86	0.00	0.36
CD4+ T Cells, donor2	11306-117C1	469.07	23.27	36.13	6.74	2.45	2.45	3.06	0.00	0.00
CD4+ T Cells, donor3	11382-118B5	334.58	25.01	22.87	8.84	2.74	3.05	2.74	0.30	0.30
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	430.58	23.74	44.16	8.93	1.02	2.04	1.28	0.26	0.51
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	474.35	23.36	44.25	4.04	1.12	1.80	2.02	0.22	0.22
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	455.34	20.41	40.53	6.04	0.00	3.16	2.01	0.29	0.57
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	474.09	33.66	33.66	8.06	2.84	10.90	2.84	0.00	0.47
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	554.83	32.31	40.73	9.13	2.11	7.73	5.62	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	533.99	29.67	72.52	3.30	3.30	3.30	6.59	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	349.87	18.06	24.57	5.20	1.01	1.45	1.16	0.29	0.14
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	311.64	16.78	36.10	4.58	1.53	1.69	1.19	0.00	0.51
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	296.46	16.12	33.21	5.32	0.97	0.81	0.48	0.16	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	368.95	26.45	18.83	6.28	1.34	2.24	1.79	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	460.49	32.49	21.66	8.04	1.40	7.34	3.49	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	428.54	25.08	20.68	11.44	1.76	6.16	3.08	0.00	0.44
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	459.59	29.09	50.60	3.79	1.26	1.26	0.84	0.84	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	325.37	13.51	25.56	3.95	0.62	1.25	0.42	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	330.79	14.70	36.09	6.35	1.00	0.00	0.00	0.33	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	423.13	29.91	23.66	7.61	1.36	4.35	2.72	0.00	0.27
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	429.83	30.55	30.55	3.75	0.00	6.97	3.75	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	539.76	16.14	41.24	8.97	3.59	1.79	1.79	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	493.61	30.04	52.48	9.27	1.11	1.30	0.00	0.37	0.37
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	473.96	26.64	47.22	8.01	1.08	1.30	1.08	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	438.38	23.96	34.89	7.78	0.63	1.47	1.68	0.21	0.21
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	466.17	32.36	36.40	5.56	2.53	4.55	3.54	0.00	0.51
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	455.35	22.96	31.19	7.80	0.43	3.47	3.03	0.00	0.43
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	512.08	31.81	32.69	5.23	2.61	8.28	3.49	0.00	0.44
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	455.28	30.68	33.16	1.98	1.48	8.91	1.98	0.00	0.49
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	469.90	21.23	36.00	6.46	1.85	6.46	1.85	0.00	2.77
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	480.16	29.31	41.87	12.56	1.40	2.79	0.00	0.00	1.40
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	554.69	34.62	34.62	4.71	1.38	7.48	8.58	0.00	0.55
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	512.13	29.45	35.58	2.94	0.98	4.42	4.66	0.00	0.98
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	434.28	18.48	23.10	4.62	1.54	0.00	1.54	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	448.72	26.50	35.81	3.22	1.43	7.52	3.94	0.00	0.72
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	581.70	37.39	51.24	6.92	1.38	8.31	1.38	0.00	0.00
CD8+ T Cells, donor1	11226-116C2	355.22	30.12	22.92	5.57	1.64	1.96	1.96	0.00	0.65
CD8+ T Cells, donor2	11307-117C2	319.87	22.90	20.65	3.38	1.13	4.13	1.50	0.38	0.00
CD8+ T Cells, donor3	11383-118B6	420.65	29.79	39.64	6.06	2.27	4.29	3.28	0.00	0.00
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	654.00	107.58	24.09	31.43	1.84	1.84	1.61	3.21	1.15
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	598.39	87.23	18.69	26.36	1.92	1.44	0.72	2.88	0.24
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	567.16	74.42	21.89	25.17	1.92	1.37	0.55	1.37	1.37
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	510.66	104.17	14.41	27.92	3.60	2.40	0.90	2.10	0.90
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	627.31	94.31	23.04	29.76	2.40	1.44	0.72	3.84	1.44
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	622.81	91.41	21.83	26.60	3.18	1.14	0.68	2.27	0.91
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	835.67	120.59	23.03	37.37	1.96	1.30	0.87	2.39	0.87
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	773.56	116.60	17.11	41.85	2.11	1.05	1.05	1.58	2.11
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	788.44	139.77	13.84	38.46	3.52	0.47	0.70	1.88	0.47
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	830.16	134.94	23.55	37.73	2.72	1.51	0.60	1.81	0.91
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	720.74	112.13	18.30	35.73	1.16	1.16	0.29	2.03	0.29
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	879.77	120.96	26.38	28.51	4.80	2.40	1.07	2.93	0.80
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	380.84	44.21	10.07	11.38	0.44	1.31	0.44	3.50	0.44
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	409.89	46.45	16.85	11.39	0.00	0.91	0.91	2.28	0.91
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	299.84	28.34	5.97	7.46	1.49	0.75	0.00	0.75	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	727.51	89.68	27.37	29.53	2.88	1.80	0.00	2.88	0.36
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	629.82	101.85	23.02	25.03	1.73	1.44	0.86	2.01	0.86
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	516.88	78.72	17.68	20.03	1.41	1.89	0.00	1.65	1.18
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	963.07	161.94	25.35	41.83	3.80	1.58	0.95	3.80	0.95
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	917.77	134.10	28.60	43.37	2.46	1.54	0.62	0.92	2.15
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	845.70	120.86	22.12	35.58	2.89	1.60	0.64	1.60	0.32
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	775.64	92.56	27.16	32.13	2.29	2.68	0.76	3.06	1.15
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	760.23	93.40	19.71	32.32	1.58	2.76	1.58	5.52	0.39
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	681.53	92.28	19.67	24.21	0.76	0.76	0.76	3.03	0.76
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	345.27	36.13	17.67	4.01	1.61	0.80	0.00	1.61	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	313.34	36.37	11.19	11.19	0.70	2.10	0.00	1.40	0.70
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	400.70	45.08	19.03	12.02	0.00	0.00	0.00	4.01	0.00
Cardiac Myocyte, donor1	11525-119I4	201.05	34.73	16.45	5.48	0.00	0.00	0.00	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	617.61	71.15	36.56	14.82	3.95	0.00	0.00	1.48	0.49
Cardiac Myocyte, donor3	11686-122I3	721.16	97.13	67.14	15.78	8.31	1.47	1.37	2.00	1.79
Chondrocyte - de diff, donor1	11261-116G1	403.17	52.69	72.45	11.09	1.39	0.69	1.39	0.00	1.73
Chondrocyte - de diff, donor2	11338-117F6	389.85	30.56	39.45	5.69	0.00	1.78	3.20	0.36	1.07
Chondrocyte - de diff, donor3	11410-118E6	372.51	34.93	50.18	6.60	2.05	1.14	0.80	0.46	0.80
Chondrocyte - re diff, donor2	11339-117F7	619.52	48.34	57.30	13.43	2.69	2.69	2.69	0.90	0.90
Chondrocyte - re diff, donor3	11411-118E7	318.27	25.07	38.82	2.43	0.81	0.81	0.40	0.00	0.81
Ciliary Epithelial Cells, donor1	11242-116D9	491.39	38.79	24.33	11.36	2.18	0.92	2.64	0.92	1.15
Ciliary Epithelial Cells, donor2	11323-117D9	536.98	58.79	34.42	17.74	6.20	0.86	1.50	1.28	0.64
Ciliary Epithelial Cells, donor3	11399-118D4	498.86	48.59	30.18	13.89	5.84	0.88	2.48	1.42	0.71
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	259.15	21.82	33.56	4.49	2.66	3.85	5.69	2.48	1.10
Corneal Epithelial Cells, donor1	11526-119I5	737.32	163.14	170.39	58.63	13.17	0.88	0.66	4.17	2.85
Corneal Epithelial Cells, donor2	11606-120I4	658.67	103.52	118.31	43.23	3.41	1.14	0.00	2.28	5.69
Corneal Epithelial Cells, donor3	11687-122I4	741.07	199.90	160.54	62.89	23.26	1.53	1.02	2.56	4.86
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	174.51	24.10	10.73	5.94	0.50	4.62	0.66	0.00	0.00
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	175.37	25.55	13.56	6.94	1.26	3.15	1.58	0.00	0.00
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	203.59	44.86	34.51	3.45	10.35	13.80	0.00	0.00	3.45
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	199.24	23.97	23.97	6.59	0.54	4.43	2.05	0.11	0.22
Dendritic Cells - plasmacytoid, donor1	11228-116C4	347.11	12.64	19.82	2.73	0.00	19.13	13.67	0.00	0.34
Dendritic Cells - plasmacytoid, donor2	11309-117C4	531.44	24.16	37.21	7.83	2.61	24.16	20.89	0.00	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	496.53	21.29	30.49	4.36	2.42	15.97	15.97	0.00	0.48
Endothelial Cells - Aortic, donor0	11207-116A1	658.24	121.41	48.53	28.85	11.84	2.17	0.33	2.33	1.33
Endothelial Cells - Aortic, donor1	11263-116G3	569.76	93.30	50.46	21.12	9.98	1.76	1.17	2.35	1.17
Endothelial Cells - Aortic, donor2	11340-117F8	545.80	68.15	37.33	18.10	5.37	0.85	1.13	1.98	1.70
Endothelial Cells - Aortic, donor3	11412-118E8	516.64	48.75	39.71	14.15	3.54	0.79	0.00	0.79	1.57
Endothelial Cells - Artery, donor1	11264-116G4	580.00	93.66	49.45	21.52	13.09	1.45	0.00	2.04	1.75
Endothelial Cells - Artery, donor2	11341-117F9	691.95	128.93	42.11	32.47	15.29	2.12	0.47	2.35	1.41
Endothelial Cells - Artery, donor3	11413-118E9	748.04	153.75	57.15	39.97	22.44	1.58	1.23	3.16	1.40
Endothelial Cells - Lymphatic, donor1	11236-116D3	295.02	30.37	35.02	6.43	2.66	0.89	0.44	1.11	1.11
Endothelial Cells - Lymphatic, donor2	11317-117D3	284.79	37.12	38.34	7.91	3.65	0.61	1.83	1.52	0.00
Endothelial Cells - Lymphatic, donor3	11393-118C7	297.69	33.26	24.53	5.92	2.82	0.56	1.41	0.85	0.85
Endothelial Cells - Microvascular, donor1	11265-116G5	626.65	93.30	49.03	26.74	14.26	2.08	0.00	3.57	2.97
Endothelial Cells - Microvascular, donor2	11342-117G1	600.33	103.61	53.11	31.24	7.29	0.00	1.56	4.69	2.08
Endothelial Cells - Microvascular, donor3	11414-118F1	406.22	41.40	40.83	8.93	5.10	1.56	2.69	2.69	1.28
Endothelial Cells - Thoracic, donor1	11266-116G6	791.84	165.25	56.42	36.01	20.81	0.40	1.20	3.20	0.40
Endothelial Cells - Thoracic, donor2	11343-117G2	606.41	77.05	43.50	18.87	6.29	0.52	1.05	3.14	1.05
Endothelial Cells - Umbilical vein, donor1	11243-116E1	530.28	112.82	44.11	30.94	12.92	1.24	1.49	2.48	0.99
Endothelial Cells - Umbilical vein, donor2	11324-117E1	322.20	54.32	29.33	13.69	12.82	0.65	1.09	0.87	0.65
Endothelial Cells - Umbilical vein, donor3	11400-118D5	400.33	81.58	41.03	28.58	17.71	0.73	0.61	2.08	1.10
Endothelial Cells - Vein, donor1	11267-116G7	693.88	128.54	43.23	31.85	28.44	2.28	0.00	2.28	0.00
Endothelial Cells - Vein, donor2	11344-117G3	763.46	128.52	34.23	34.93	9.08	0.70	1.40	4.89	2.10
Endothelial Cells - Vein, donor3	11416-118F3	676.39	106.61	50.87	23.71	21.20	1.26	1.57	3.77	1.10
Eosinophils, donor1	12244-129H3	228.70	0.00	15.25	0.00	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	612.25	42.91	9.90	3.30	1.65	9.90	1.65	0.00	0.00
Eosinophils, donor3	12246-129H5	599.23	46.37	17.83	3.57	3.57	3.57	3.57	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	558.53	144.40	104.82	46.67	13.44	1.71	0.24	1.71	2.44
Esophageal Epithelial Cells, donor2	11587-120G3	282.90	79.05	83.21	16.64	4.16	0.00	0.00	0.00	4.16
Esophageal Epithelial Cells, donor3	11668-122G3	553.14	113.88	48.81	0.00	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	230.30	17.24	38.18	4.11	0.41	1.64	0.82	0.00	0.41
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	294.85	46.64	64.93	10.29	1.97	0.33	0.00	1.20	0.88
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	457.51	43.12	73.99	9.10	0.87	0.87	0.43	1.19	1.63
Fibroblast - Aortic Adventitial, donor1	11245-116E3	640.84	112.67	66.34	22.19	5.70	0.85	0.61	2.30	1.58
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	411.60	69.74	29.75	13.92	7.10	0.41	0.14	0.68	0.96
Fibroblast - Aortic Adventitial, donor2	11326-117E3	432.32	50.94	63.49	11.07	2.43	0.42	0.42	0.74	1.16
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	304.07	47.96	13.96	5.80	2.11	0.53	0.26	0.00	0.79
Fibroblast - Aortic Adventitial, donor3	11401-118D6	542.15	83.71	58.47	14.28	5.98	1.00	1.33	1.00	2.66
Fibroblast - Cardiac, donor1	11268-116G8	650.50	84.37	65.32	18.60	5.44	1.81	0.45	1.36	0.45
Fibroblast - Cardiac, donor2	11345-117G4	994.43	155.38	45.48	28.04	3.03	0.00	0.76	4.55	0.76
Fibroblast - Cardiac, donor3	11417-118F4	559.26	84.85	57.41	13.88	5.20	1.10	1.26	1.89	1.89
Fibroblast - Cardiac, donor4	11452-119A3	366.76	40.01	37.59	10.61	3.94	0.30	1.21	0.61	0.91
Fibroblast - Cardiac, donor5	11456-119A7	438.45	71.32	51.14	14.47	5.20	1.02	0.89	1.65	1.27
Fibroblast - Cardiac, donor6	11460-119B2	539.52	100.20	52.60	16.98	7.28	1.06	1.06	2.12	1.52
Fibroblast - Choroid Plexus, donor1	11492-119E7	622.65	41.94	50.25	8.84	2.95	1.61	2.55	1.74	1.34
Fibroblast - Choroid Plexus, donor2	11572-120E6	317.96	21.14	16.83	4.31	2.59	0.00	3.45	0.86	0.00
Fibroblast - Choroid Plexus, donor3	11653-122E6	763.16	130.37	49.80	32.23	10.25	2.93	2.93	0.00	1.46
Fibroblast - Conjunctival, donor1	11531-120A1	1018.04	177.82	91.79	58.35	13.38	1.85	1.85	4.84	2.54
Fibroblast - Conjunctival, donor3	11692-122I9	293.42	16.62	12.21	3.73	0.34	0.51	5.94	0.17	0.34
Fibroblast - Dermal, donor1	11269-116G9	571.69	125.37	111.76	48.36	19.49	0.23	0.00	3.76	3.29
Fibroblast - Dermal, donor2	11346-117G5	904.21	217.92	83.49	95.75	19.81	0.94	0.47	4.25	0.47
Fibroblast - Dermal, donor3	11418-118F5	600.92	126.93	115.81	35.66	10.28	1.21	0.48	2.42	2.18
Fibroblast - Dermal, donor4	11450-119A1	511.76	99.93	57.77	29.62	15.15	1.36	0.57	1.58	1.92
Fibroblast - Dermal, donor5	11454-119A5	585.64	96.30	69.78	34.02	10.64	1.05	0.70	1.92	0.87
Fibroblast - Dermal, donor6	11458-119A9	674.38	118.89	73.74	33.78	13.97	1.62	0.65	1.95	1.30
Fibroblast - Gingival, donor1	11237-116D4	384.39	70.80	70.59	21.03	5.41	0.21	2.08	0.21	1.46
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	423.13	50.83	49.78	12.05	3.14	1.05	0.26	0.52	1.57
Fibroblast - Gingival, donor2	11318-117D4	562.59	87.11	57.59	27.02	11.86	1.98	1.05	1.58	1.58
Fibroblast - Gingival, donor3	11394-118C8	281.07	33.26	51.82	9.57	2.61	1.06	1.16	0.39	0.39
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	326.21	21.82	35.32	3.12	1.04	0.00	0.00	0.00	1.04
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	244.04	20.97	32.25	4.23	0.35	0.18	0.70	0.35	0.53
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	645.57	86.05	50.04	30.40	5.14	0.47	0.62	1.09	1.25
Fibroblast - Gingival, donor6 (control)	11922-125H5	602.17	77.76	51.25	24.88	5.00	1.22	0.68	0.68	1.49
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	1852.62	256.90	205.73	70.93	15.53	2.47	2.12	1.76	6.70
Fibroblast - Gingival, donor7 (control)	11924-125H7	470.03	58.79	48.70	16.96	2.34	0.88	0.44	0.73	1.02
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	594.77	69.95	41.86	24.27	2.32	0.55	0.41	0.55	0.41
Fibroblast - Gingival, donor8 (control)	11926-125H9	545.72	110.24	42.89	28.30	4.61	0.88	0.66	0.88	1.21
Fibroblast - Gingival, donor9 (control)	11927-125I1	192.67	7.63	15.99	2.05	0.15	1.03	1.17	0.29	0.00
Fibroblast - Lung, donor1	11270-116H1	652.49	91.08	59.81	17.67	8.16	1.36	2.72	2.72	1.36
Fibroblast - Lung, donor2	11347-117G6	462.57	62.67	59.69	14.92	2.98	2.98	0.00	0.00	2.98
Fibroblast - Lung, donor3	11419-118F6	709.08	102.99	83.15	23.42	9.50	2.74	1.69	1.90	1.48
Fibroblast - Lymphatic, donor1	11506-119G3	1252.03	199.09	128.29	76.64	4.17	0.00	1.67	5.00	0.83
Fibroblast - Lymphatic, donor2	11586-120G2	458.75	55.95	99.30	11.19	9.79	0.00	0.00	2.80	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	616.85	66.33	86.20	24.63	3.36	0.00	0.56	1.96	1.68
Fibroblast - Mammary, donor1	11540-120B1	887.04	189.59	90.53	63.74	13.40	1.22	2.03	5.28	3.25
Fibroblast - Mammary, donor2	11620-122A9	850.77	123.82	119.83	27.96	0.00	7.99	0.00	7.99	0.00
Fibroblast - Mammary, donor3	11701-123A9	494.37	113.17	53.61	11.91	0.00	5.96	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	636.04	101.64	47.72	35.50	6.60	1.36	1.36	1.55	0.97
Fibroblast - Periodontal Ligament, donor2	11319-117D5	511.47	103.60	42.62	29.73	13.95	0.76	0.46	1.52	1.06
Fibroblast - Periodontal Ligament, donor3	11395-118C9	462.65	94.86	67.62	29.99	11.93	0.61	0.92	0.92	1.53
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	404.52	36.64	38.54	7.25	4.96	0.76	0.76	0.76	2.29
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	446.83	52.38	57.24	15.66	3.24	0.54	0.81	0.27	0.81
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	232.18	20.30	33.86	4.18	1.51	0.35	0.81	0.12	0.58
Fibroblast - Pulmonary Artery, donor1	11250-116E8	857.07	173.43	70.52	41.01	9.51	1.55	1.33	2.43	1.99
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	721.53	112.36	62.18	37.79	7.31	1.42	0.61	1.83	0.81
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	767.77	100.23	85.53	22.72	8.02	0.67	2.67	0.67	1.34
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	581.58	77.49	56.54	17.40	3.95	0.79	1.98	1.98	1.19
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	368.72	62.31	8.33	14.09	6.35	0.60	0.79	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	347.24	21.49	47.07	4.09	0.71	1.24	0.71	0.36	0.36
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	473.00	49.07	50.45	7.29	1.58	0.99	0.39	0.59	0.79
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	373.36	71.00	16.55	15.34	5.42	0.60	0.90	0.30	0.00
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	562.00	75.13	54.73	12.31	3.13	0.65	0.65	0.43	1.08
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	436.81	51.37	7.59	8.10	4.05	0.76	0.51	0.25	0.00
Fibroblast - skin normal, donor1	11553-120C5	481.73	39.05	59.07	10.67	1.31	0.66	0.98	0.00	0.98
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	339.06	67.97	12.83	15.44	8.22	0.40	0.40	0.40	0.00
Fibroblast - skin normal, donor2	11561-120D4	743.22	110.21	65.10	20.80	4.02	1.21	1.11	0.90	1.21
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	499.60	89.16	10.58	12.39	8.46	0.60	1.81	0.00	0.00
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	352.43	29.24	48.96	5.30	0.50	1.24	0.66	0.33	0.41
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	393.53	44.79	38.98	6.50	2.91	1.03	1.20	0.17	0.34
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	318.25	44.01	13.14	7.88	3.61	0.33	0.66	0.33	0.66
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	766.53	97.04	82.02	16.51	6.18	0.96	1.70	1.38	0.85
Fibroblast - skin walker warburg, donor1	11554-120C6	765.98	94.29	55.33	21.42	6.58	3.54	1.35	1.18	1.52
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	406.79	45.01	43.60	7.37	2.67	0.94	1.41	0.63	0.78
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	1462.55	199.44	88.64	66.48	22.16	22.16	0.00	0.00	22.16
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	369.53	52.29	103.71	17.43	4.36	0.87	0.00	0.00	1.74
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	384.85	74.72	67.09	23.06	4.51	0.69	0.52	1.56	0.87
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	480.93	84.06	90.56	28.63	15.35	1.04	0.78	1.82	1.04
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	384.80	82.28	98.37	29.64	11.50	0.26	0.00	1.53	1.28
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	680.58	106.41	53.59	52.82	6.89	8.42	0.77	26.03	1.53
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	816.09	138.46	47.86	65.08	8.29	9.57	3.83	33.82	3.83
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	688.06	98.99	81.59	41.65	37.94	3.99	3.14	26.81	3.71
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	276.86	14.06	16.82	3.58	3.58	3.58	3.03	1.38	0.55
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	277.87	26.49	18.27	6.39	2.97	1.60	1.37	3.65	0.23
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	437.67	55.87	58.05	21.40	20.21	4.36	0.79	13.27	1.78
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	297.64	14.80	23.53	4.23	5.02	2.11	1.85	1.59	0.53
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	274.29	9.46	15.33	3.26	1.30	1.30	1.63	1.30	1.30
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	659.36	76.50	71.20	38.47	15.48	3.54	1.33	29.19	3.54
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	597.65	57.94	45.08	26.29	17.52	7.07	6.92	9.33	3.82
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	487.89	43.84	22.54	13.79	12.31	4.56	4.19	4.56	1.11
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	538.86	78.71	40.83	33.31	19.07	6.72	6.72	9.40	1.61
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	608.57	64.67	14.87	15.12	9.42	4.34	2.11	3.22	0.74
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	654.34	78.76	18.00	22.29	11.63	6.37	3.88	6.23	0.55
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	556.03	83.56	19.92	25.21	12.81	7.52	3.25	7.73	0.81
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	423.27	33.77	15.74	8.90	5.02	4.56	1.37	1.83	0.46
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	414.80	34.50	16.32	8.47	6.23	3.49	2.49	2.74	0.25
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	363.49	32.35	18.58	12.02	9.84	1.75	3.72	4.59	0.66
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	449.42	42.84	14.48	5.02	4.73	5.61	4.43	1.18	0.30
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	447.15	33.54	17.01	6.68	4.13	2.23	3.02	2.86	0.79
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	388.53	32.40	16.98	8.04	7.60	3.35	3.57	1.79	0.67
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	486.14	31.45	13.31	8.87	5.24	4.03	4.84	2.62	0.20
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	538.10	35.12	14.93	9.33	2.71	3.56	2.04	2.21	0.34
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	509.33	49.21	16.76	11.70	3.46	5.23	3.19	3.37	0.53
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	502.80	42.04	16.34	9.37	2.60	3.54	3.43	1.46	0.21
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	644.34	42.18	18.10	12.98	2.73	5.12	5.29	2.22	0.34
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	459.10	28.33	16.04	7.64	3.10	3.65	2.77	1.99	0.55
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	482.70	38.69	15.81	11.48	3.66	4.24	2.58	2.91	0.25
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	632.35	47.37	18.17	15.72	4.29	5.10	2.65	2.25	0.41
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	434.27	29.50	11.14	4.95	3.71	2.89	3.09	1.24	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	436.73	24.67	12.45	4.27	2.31	3.69	3.11	1.27	0.12
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	515.64	47.69	13.84	10.01	8.34	4.00	4.00	3.17	0.83
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	352.47	26.45	9.04	6.83	2.65	3.09	2.65	0.88	0.66
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	441.17	26.69	13.90	6.03	2.95	3.44	1.72	0.98	0.12
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	441.22	40.52	15.72	10.05	6.16	2.76	3.89	2.59	0.49
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	298.26	21.49	9.94	3.85	2.25	2.89	2.89	0.64	0.32
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	442.22	28.90	14.50	7.01	3.03	1.71	2.37	0.85	0.28
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	478.80	46.98	15.03	9.02	4.11	4.90	2.06	2.21	0.32
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	406.26	29.19	11.86	5.47	3.34	1.82	1.22	1.22	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	510.98	40.46	14.74	7.42	3.24	2.20	3.35	1.78	0.10
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	382.03	32.49	14.27	5.93	1.98	1.76	1.32	1.10	0.44
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	393.61	26.09	12.06	4.49	3.09	3.09	1.96	0.56	0.28
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	400.35	31.02	14.91	6.85	2.59	1.11	2.04	1.30	1.02
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	488.81	46.53	18.72	11.23	5.08	1.87	2.67	3.21	0.27
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	474.93	51.41	20.04	12.70	5.66	2.14	2.30	1.22	0.46
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	530.19	58.68	19.30	10.36	5.31	2.20	1.30	3.24	0.52
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	368.12	35.51	19.25	5.15	5.69	1.08	1.08	1.36	0.81
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	375.52	29.68	16.04	5.90	2.21	1.66	2.21	0.37	0.37
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	362.52	23.25	16.45	5.70	1.54	1.54	2.41	0.00	0.22
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	192.40	7.93	6.94	1.98	0.99	3.97	3.97	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	399.56	21.11	18.34	4.88	2.77	1.98	0.92	0.40	0.26
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	376.68	21.18	17.96	2.62	1.01	1.41	1.82	0.00	0.40
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	274.49	15.00	7.12	1.52	1.02	2.03	5.08	0.51	0.51
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	937.57	122.62	52.35	37.42	31.05	9.75	5.57	22.69	3.18
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	578.25	63.94	47.61	21.26	19.11	7.09	4.47	8.94	2.47
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	744.68	65.47	49.10	21.69	16.16	7.36	3.68	14.32	2.66
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	945.67	106.08	46.63	34.11	12.83	8.76	8.14	24.10	3.44
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	968.04	122.35	48.32	45.77	10.45	10.45	4.80	24.30	2.54
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	682.58	55.34	41.05	22.60	10.15	8.30	4.15	18.91	2.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	608.80	86.62	44.55	22.27	7.42	14.85	4.95	12.37	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	694.71	97.86	37.91	34.43	10.44	11.99	8.12	13.15	2.71
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	757.31	94.66	33.69	41.72	4.81	8.02	4.81	6.42	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	624.24	50.43	26.08	20.87	1.74	3.48	3.48	6.96	1.74
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	588.14	66.07	25.06	17.90	8.14	5.53	7.49	9.11	1.63
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	585.17	59.30	27.59	20.59	8.24	6.59	7.41	4.94	2.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	476.51	46.65	13.33	26.66	6.66	3.33	0.00	6.66	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	481.55	49.22	20.41	12.30	5.03	5.59	6.43	3.36	0.56
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	543.87	55.56	17.00	17.32	5.88	5.23	3.92	5.88	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	425.29	38.59	15.94	14.26	8.39	2.52	7.55	4.19	0.84
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	530.54	40.08	15.59	11.77	4.77	4.13	3.82	3.18	1.27
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	574.03	48.23	21.06	16.98	3.74	10.53	3.06	2.38	0.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	545.01	45.94	18.79	4.18	10.44	8.35	4.18	6.26	2.09
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	600.76	42.38	17.75	14.32	6.30	6.87	4.01	3.44	1.15
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	473.28	31.97	20.42	10.06	6.51	4.74	4.14	2.66	1.18
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	398.12	40.66	13.55	5.08	3.39	3.39	1.69	1.69	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	594.80	45.98	15.33	14.91	3.31	8.28	7.87	4.97	0.83
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	522.16	36.82	17.72	11.51	4.60	8.74	9.21	4.60	0.46
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	447.82	31.61	10.54	10.54	10.54	5.27	10.54	10.54	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	445.15	28.83	13.07	6.15	2.31	4.61	3.46	1.92	0.38
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	382.69	19.56	9.78	6.52	2.28	8.15	4.24	0.65	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	335.76	18.73	10.70	5.35	1.34	2.68	0.67	1.34	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	382.19	20.42	6.93	6.93	2.31	4.24	3.85	0.39	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	438.54	29.44	8.90	8.90	3.08	2.74	5.82	4.79	0.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	325.51	19.88	0.00	2.48	4.97	4.97	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	305.29	12.74	10.38	2.36	2.36	4.72	2.36	1.42	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	404.34	18.71	7.85	0.60	1.21	2.41	5.43	0.00	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	336.74	14.24	6.61	3.56	0.51	5.09	3.05	1.02	0.51
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	364.54	18.35	10.37	1.99	1.60	4.79	4.79	0.80	0.40
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	369.52	13.32	10.36	1.97	1.97	5.43	3.95	0.99	0.49
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	396.63	21.25	5.90	1.18	3.54	3.54	3.54	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	370.49	19.25	9.92	0.58	1.17	5.83	3.50	1.17	1.17
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	318.19	13.17	4.39	0.88	2.19	2.19	3.07	1.32	0.44
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	297.54	11.02	5.93	0.00	1.70	2.54	1.70	0.85	0.85
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	383.82	13.13	11.34	4.18	0.60	2.39	5.37	1.19	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	364.91	27.66	5.82	3.88	1.46	5.34	2.43	0.49	0.49
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	748.69	61.63	81.03	14.84	6.85	2.28	1.14	2.28	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	523.51	29.52	57.80	9.15	1.25	0.83	2.08	0.83	0.83
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	1131.20	118.07	100.08	38.23	13.49	1.12	1.12	3.37	6.75
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	231.84	27.59	54.55	7.29	0.95	1.27	1.59	1.90	1.59
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	280.30	46.79	93.16	15.46	2.51	2.51	2.09	0.42	2.92
Hep-2 cells mock treated, biol_rep1	11898-125E8	948.88	205.16	97.94	57.09	26.46	1.74	0.23	2.55	3.83
Hep-2 cells mock treated, biol_rep2	11899-125E9	1064.46	210.66	101.45	68.36	25.66	1.86	0.51	2.36	4.22
Hep-2 cells mock treated, biol_rep3	11900-125F1	1023.31	224.55	103.97	63.93	27.53	1.14	0.00	2.28	3.41
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	929.89	217.42	98.71	56.73	23.17	2.40	1.31	1.42	3.83
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	1110.88	225.44	105.52	74.57	27.08	2.15	0.86	3.22	6.45
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	1008.38	216.36	94.08	70.61	25.40	1.72	0.86	2.15	4.52
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	1015.98	227.28	102.37	58.03	30.01	1.62	0.75	1.87	4.48
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	1104.09	211.18	101.90	68.96	22.82	1.37	0.86	2.57	4.12
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	1005.01	242.84	103.48	61.19	24.99	1.60	1.28	3.52	5.77
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	457.77	59.32	51.49	9.51	9.51	1.12	2.80	2.24	1.68
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	782.92	119.02	64.92	39.38	4.33	1.73	1.73	2.60	2.60
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	753.48	148.05	37.01	42.30	7.93	2.64	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	820.78	97.70	63.49	29.63	6.35	0.71	2.12	2.47	1.41
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	747.58	73.38	61.03	17.44	2.18	1.45	2.91	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	827.69	179.56	69.59	43.36	20.28	1.57	1.22	2.27	1.57
Hepatocyte, donor1	11523-119I2	380.13	38.74	8.47	8.47	4.84	1.21	0.00	0.00	0.00
Hepatocyte, donor2	11603-120I1	432.01	39.86	7.54	4.31	4.31	1.08	1.08	1.08	0.00
Hepatocyte, donor3	11684-122I1	339.90	57.06	13.50	9.20	1.23	1.84	0.00	0.00	0.61
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	298.93	58.09	20.89	11.75	13.71	3.26	2.61	0.00	0.00
Intestinal epithelial cells (polarized), donor1	11246-116E4	122.52	21.32	8.04	2.10	1.22	1.92	0.52	0.52	0.17
Iris Pigment Epithelial Cells, donor1	11530-119I9	548.14	87.13	45.83	24.97	11.11	0.55	0.96	2.20	1.23
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	710.01	89.15	28.66	60.49	35.02	0.00	0.00	6.37	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	821.06	93.45	26.70	46.73	6.68	0.00	6.68	0.00	6.68
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	541.67	216.67	0.00	81.25	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	760.02	121.83	18.00	42.92	15.23	4.15	2.77	2.77	1.38
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	855.91	165.18	25.03	55.06	17.52	2.50	0.00	0.00	5.01
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	1258.04	332.31	0.00	130.55	23.74	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	763.75	138.40	23.07	33.32	15.38	0.00	0.00	5.13	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	754.18	173.69	13.71	50.28	4.57	0.00	0.00	13.71	4.57
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	888.51	134.82	30.86	56.85	19.49	4.87	0.00	1.62	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	790.30	105.04	18.34	46.68	8.34	6.67	0.00	1.67	1.67
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	758.79	83.50	32.68	43.57	3.63	3.63	0.00	0.00	3.63
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	895.99	125.73	37.06	54.26	23.82	5.29	2.65	1.32	1.32
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	747.23	133.04	33.26	44.35	14.41	2.22	2.22	3.33	2.22
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	743.84	99.53	5.24	41.91	10.48	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	669.54	96.37	24.56	25.82	9.45	3.78	0.00	0.63	0.63
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	784.14	125.28	32.48	43.31	23.20	4.64	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	453.68	58.54	0.00	14.63	14.63	0.00	0.00	14.63	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	791.40	110.47	38.12	47.81	13.57	3.88	2.58	3.88	1.94
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	772.76	130.40	33.81	30.59	12.88	1.61	1.61	4.83	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	501.82	83.64	35.84	11.95	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	793.69	113.27	29.34	44.82	3.26	2.44	0.81	4.07	0.81
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	934.50	152.39	25.19	62.13	9.24	2.52	1.68	7.56	0.84
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	445.55	28.74	28.74	14.37	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	684.74	98.85	21.70	46.61	7.23	0.80	0.00	0.80	2.41
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	702.62	125.57	34.16	36.93	21.24	2.77	0.92	4.62	2.77
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	452.42	15.08	15.08	45.24	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	766.59	113.29	31.63	40.60	8.97	4.25	2.36	4.25	2.83
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	727.40	115.19	27.21	37.19	18.14	1.81	0.00	5.44	0.91
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	427.53	44.23	29.48	44.23	14.74	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	750.06	114.07	35.51	43.04	7.53	2.15	0.00	5.38	2.15
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	1030.35	146.10	29.22	60.98	20.33	2.54	1.27	8.89	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	361.47	147.87	32.86	32.86	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	744.17	111.59	30.61	36.99	7.01	1.91	1.28	5.74	3.19
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	847.54	120.30	23.69	60.15	20.05	0.00	0.00	3.65	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	426.72	63.22	15.80	63.22	15.80	0.00	0.00	0.00	15.80
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	743.34	98.54	25.71	34.28	10.71	4.28	2.14	4.28	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	826.26	146.01	36.50	59.73	13.27	3.32	0.00	16.59	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	521.21	62.55	0.00	20.85	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	713.31	98.77	30.56	37.97	8.33	4.32	2.47	3.70	1.23
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	827.09	107.12	35.12	42.14	21.07	3.51	1.76	7.02	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	653.77	66.01	18.86	44.00	6.29	9.43	6.29	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	655.06	97.35	35.46	34.77	4.17	2.09	2.09	4.87	1.39
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	1082.20	135.00	50.90	57.54	17.70	2.21	0.00	6.64	2.21
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	894.80	142.65	19.45	38.90	9.73	6.48	3.24	9.73	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	734.17	108.99	25.29	32.26	11.34	1.74	0.87	0.87	1.74
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	888.66	132.74	20.25	58.49	18.00	2.25	0.00	2.25	2.25
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	804.94	135.90	31.36	45.30	6.97	10.45	0.00	3.48	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	738.21	102.41	35.20	25.60	2.13	3.20	1.07	1.07	4.27
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	775.85	130.23	42.95	34.64	18.01	4.16	4.16	5.54	1.39
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	923.27	131.08	28.50	22.80	8.55	8.55	2.85	2.85	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	830.22	125.18	21.17	36.82	4.60	1.84	1.84	1.84	3.68
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	626.24	63.53	36.30	21.18	6.05	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	745.04	80.71	37.25	43.46	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	561.46	50.75	37.01	14.80	3.17	1.06	0.00	2.11	4.23
Keratinocyte - epidermal, donor1	11272-116H3	411.50	103.06	79.15	47.41	7.10	0.57	0.41	2.20	0.90
Keratinocyte - epidermal, donor2	11349-117G8	727.94	203.22	87.26	65.01	9.96	0.00	0.00	2.34	2.34
Keratinocyte - epidermal, donor3	11421-118F8	653.22	148.04	82.73	40.04	26.41	2.37	1.04	1.42	3.31
Keratinocyte - oral, donor1	11251-116E9	544.66	121.01	103.53	39.96	8.17	1.02	1.82	1.59	2.38
Keratocytes, donor1	11527-119I6	1195.85	155.07	130.31	43.67	12.03	2.06	1.38	2.75	3.09
Keratocytes, donor2	11607-120I5	751.12	157.02	84.37	51.56	12.89	0.00	1.17	4.69	2.34
Keratocytes, donor3	11688-122I5	400.73	30.43	47.03	4.54	1.38	0.40	0.59	0.59	0.40
Krukenberg tumor cell line:HSKTC	10687-109F3	153.85	8.79	10.99	0.00	4.40	2.20	0.00	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	660.19	62.57	59.33	34.52	5.39	1.08	0.00	0.00	1.08
Lens Epithelial Cells, donor2	11609-120I7	330.54	16.72	19.95	3.58	1.15	1.61	6.00	0.35	0.12
Lens Epithelial Cells, donor3	11690-122I7	425.43	65.69	37.44	11.50	5.15	0.50	1.31	1.31	0.81
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	555.53	96.17	55.73	27.51	12.09	2.37	3.68	3.08	1.90
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	434.80	76.19	30.14	22.33	6.14	1.67	2.79	2.51	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	362.21	64.70	34.63	14.17	6.14	1.10	0.94	2.52	0.79
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	490.40	84.42	44.09	28.50	5.91	1.61	1.08	1.08	1.61
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	417.91	56.41	30.57	17.33	5.04	0.95	0.95	1.58	0.95
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	381.34	61.24	34.39	16.93	6.15	0.86	1.62	1.83	1.08
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	446.92	67.71	35.29	25.03	2.05	0.82	2.46	2.05	0.82
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	524.60	84.69	41.97	26.04	5.06	0.76	2.53	2.02	0.51
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	374.11	59.82	35.19	13.65	5.21	1.13	1.13	2.82	0.99
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	410.17	63.29	32.43	15.82	3.96	1.19	1.58	3.16	0.40
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	455.43	71.35	33.35	20.55	5.04	0.97	1.74	3.49	0.78
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	464.54	69.06	43.70	16.29	6.11	1.11	1.30	2.41	1.11
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	448.07	87.11	43.20	18.81	7.32	2.09	3.14	2.79	1.05
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	530.48	77.28	36.02	21.71	5.01	2.39	1.19	2.39	1.91
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	413.69	64.69	35.85	15.38	5.22	1.37	2.33	3.16	0.55
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	457.01	67.13	29.26	17.55	6.47	0.92	2.46	2.46	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	512.51	85.73	35.85	21.51	6.23	2.81	0.31	1.87	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	441.01	72.10	34.04	20.31	5.67	0.73	0.91	2.20	1.28
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	463.72	85.24	41.47	21.06	4.28	1.32	2.96	3.95	0.99
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	522.48	76.44	30.17	21.09	3.22	1.76	3.22	2.64	0.59
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	502.84	80.40	28.63	20.66	4.73	1.24	2.24	2.24	0.75
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	446.65	67.41	37.83	21.34	6.30	1.45	2.42	0.97	1.45
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	489.04	72.17	36.36	20.74	8.62	0.54	1.62	2.15	0.54
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	391.92	57.67	31.94	14.53	4.24	0.91	1.21	3.03	0.15
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	483.16	77.24	25.92	25.40	3.63	0.52	2.59	3.63	0.52
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	490.81	76.85	39.16	19.05	7.12	1.26	1.47	2.51	0.42
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	407.21	65.11	34.28	14.44	5.86	1.20	1.50	2.41	1.35
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	490.46	85.30	35.08	20.64	4.13	2.06	0.69	0.69	0.69
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	478.46	75.64	37.82	20.32	4.14	0.94	1.13	0.94	0.56
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	406.20	65.84	38.49	14.84	5.94	1.59	1.80	2.12	0.85
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	460.83	83.35	34.89	19.38	5.33	0.48	1.94	1.45	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	494.86	60.87	29.77	21.17	4.30	1.98	1.32	2.32	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	413.67	63.56	36.67	13.75	3.72	0.74	1.73	2.23	0.87
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	423.52	59.23	31.84	20.73	2.96	0.74	1.11	2.59	2.22
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	512.20	76.60	30.89	16.55	4.45	0.74	2.72	1.73	0.74
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	423.76	65.72	36.99	13.89	4.67	0.96	1.92	3.16	0.82
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	442.57	60.15	36.67	17.69	6.75	0.32	1.61	3.22	0.64
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	475.06	71.21	30.43	23.43	3.04	0.91	3.96	1.52	0.91
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	389.25	61.17	30.09	14.98	3.92	0.70	1.68	2.52	0.98
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	472.54	71.11	30.93	20.98	2.49	1.78	1.42	1.78	0.71
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	569.13	76.59	27.15	15.51	3.88	0.97	3.39	0.97	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	465.58	73.60	39.37	13.38	4.51	1.56	1.09	2.49	0.62
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	491.32	92.75	35.45	28.29	8.24	1.43	2.51	1.79	0.36
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	519.09	80.69	29.07	16.01	7.19	2.29	1.31	1.31	0.65
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	487.80	75.10	38.37	20.01	6.12	0.71	2.83	2.59	1.88
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	541.29	96.03	46.53	23.02	9.65	1.86	2.85	2.97	0.62
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	521.48	86.57	38.68	17.16	6.66	0.77	2.05	2.05	0.26
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	440.08	73.10	32.82	13.72	9.55	1.19	1.49	2.09	1.79
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	641.28	106.50	24.93	13.60	4.53	2.27	4.53	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	607.57	73.64	32.99	14.58	7.67	3.07	0.77	0.77	0.77
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	581.91	71.25	34.14	19.30	6.68	2.97	0.74	2.23	0.74
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	536.95	60.08	22.00	13.54	1.69	2.12	1.69	0.42	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	573.91	86.51	33.76	16.88	7.74	2.81	0.00	0.00	1.41
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	647.24	85.92	37.36	11.21	4.67	3.74	1.87	0.00	0.93
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	522.48	59.26	23.70	20.61	2.06	1.03	2.06	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	601.87	74.94	28.55	11.89	14.27	3.57	1.19	2.38	1.19
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	631.30	103.14	38.23	18.32	4.98	3.39	3.17	0.68	0.90
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	433.91	54.38	21.81	13.38	2.33	1.74	1.45	0.29	0.29
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	514.55	51.77	29.71	13.06	7.65	1.35	1.80	0.45	1.35
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	723.49	103.65	43.22	18.70	3.12	2.85	2.71	0.27	0.54
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	557.69	69.84	26.19	14.38	1.54	4.62	1.03	1.03	0.51
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	503.88	67.75	27.52	12.00	7.06	1.76	1.41	0.35	1.06
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	525.71	51.31	23.99	9.99	6.00	2.67	3.33	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	540.46	61.13	25.47	16.81	4.08	3.57	3.06	0.00	1.02
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	503.73	67.77	31.48	8.54	6.94	1.60	3.74	0.80	0.80
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	472.55	66.70	27.96	13.23	4.91	3.02	1.32	0.57	0.76
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	581.04	81.60	27.00	13.50	2.45	1.84	4.29	0.61	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	606.67	88.88	41.59	18.75	10.60	1.63	2.45	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	457.72	60.39	26.86	12.70	3.12	1.25	1.46	0.21	0.62
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	504.47	55.21	24.10	14.57	2.24	0.84	0.84	0.56	0.56
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	594.51	78.31	44.30	17.52	7.21	5.15	2.06	0.00	2.06
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	496.13	73.16	29.61	13.93	6.97	1.16	1.74	0.00	0.29
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	457.96	55.30	22.42	11.36	0.90	2.39	0.90	0.30	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	460.31	68.60	37.07	7.75	6.64	3.32	4.43	0.55	1.11
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	586.08	83.42	36.41	11.67	3.89	3.18	0.71	0.71	1.41
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	510.39	47.94	26.55	13.28	2.95	2.95	1.48	0.37	0.74
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	645.87	79.44	28.78	18.42	4.61	3.45	2.30	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	633.58	85.19	30.32	13.82	6.14	2.30	0.77	0.77	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	581.42	70.20	26.04	17.55	2.26	2.83	1.70	0.57	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	581.71	78.76	22.15	20.51	8.20	1.64	3.28	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	618.18	91.28	32.99	17.62	7.23	4.07	1.36	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	643.46	73.25	31.60	12.93	7.18	5.03	1.44	2.15	0.72
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	653.54	97.10	33.61	13.44	7.47	2.24	2.24	0.00	2.99
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	569.28	84.72	33.81	17.09	8.18	2.97	0.74	0.37	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	603.48	69.78	27.57	15.08	2.15	3.02	0.43	0.00	1.29
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	691.03	101.04	34.25	17.13	10.28	3.43	5.14	0.00	0.86
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	654.03	94.96	37.65	14.99	8.00	3.66	2.00	1.33	0.67
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	688.98	80.24	28.96	24.13	5.43	1.81	1.81	1.21	1.21
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	752.95	125.85	37.68	19.20	9.24	2.84	4.98	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	607.69	88.68	34.03	16.15	3.44	2.75	2.41	0.34	0.34
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	709.04	81.05	28.98	12.88	2.68	4.29	1.61	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	647.77	113.12	32.99	13.47	8.75	1.35	1.35	2.02	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	586.73	92.97	31.48	20.74	7.04	1.48	2.22	0.00	0.74
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	779.16	127.92	40.70	26.75	6.98	3.49	3.49	0.00	1.16
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	743.59	117.41	49.71	17.98	7.40	2.12	1.06	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	648.24	104.84	31.61	20.81	6.40	3.20	1.20	0.40	0.40
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	637.47	65.42	32.71	18.90	2.91	0.00	0.73	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	761.92	95.05	27.59	19.16	10.73	1.53	1.53	0.00	0.77
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	612.65	70.54	37.00	13.81	7.40	1.48	0.99	0.49	0.49
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	575.85	50.81	23.52	15.05	1.88	1.88	1.88	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	672.77	90.51	38.72	16.09	9.05	2.01	3.02	0.00	2.01
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	588.51	71.20	27.04	22.53	3.15	3.15	4.96	0.00	0.45
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	638.53	67.12	36.14	12.05	3.44	6.88	0.00	1.72	1.72
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	648.42	81.50	39.64	15.59	8.02	4.01	2.23	0.89	0.45
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	560.34	87.59	40.28	17.21	7.04	1.96	1.17	0.39	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	543.62	75.87	23.09	13.19	1.98	1.32	1.98	0.66	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	656.96	97.04	38.40	14.53	8.30	2.08	1.56	1.56	0.52
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	611.28	92.76	35.44	18.38	7.00	3.50	0.44	0.44	0.44
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	544.01	72.12	25.16	15.10	3.35	3.91	1.12	1.68	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	612.12	84.35	33.56	14.57	8.39	1.77	1.77	0.00	0.88
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	558.90	82.93	28.16	11.57	5.79	0.77	3.09	0.39	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	569.65	78.99	27.85	20.25	3.54	2.53	0.51	0.00	0.51
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	621.92	93.72	30.76	22.59	6.25	2.40	2.40	0.48	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	599.10	88.26	28.23	15.11	7.16	4.77	1.99	0.40	0.80
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	567.52	78.99	20.66	12.15	1.22	3.04	0.61	0.00	0.61
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	498.03	76.09	26.28	17.29	2.77	1.38	3.46	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	579.87	98.42	26.60	13.30	7.60	1.52	1.14	0.38	0.38
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	606.27	72.81	25.82	14.46	3.10	2.58	1.03	0.00	0.52
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	494.61	98.56	24.79	12.70	3.02	0.60	3.02	0.00	1.21
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	573.91	94.12	32.64	17.11	7.61	1.90	0.95	0.00	0.32
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	593.86	74.10	22.92	20.26	1.60	5.33	0.53	1.07	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	643.63	113.21	25.86	15.52	5.17	3.45	2.30	0.57	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	613.48	115.19	33.43	18.51	5.14	3.09	2.06	1.03	0.51
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	673.40	82.05	29.00	21.93	2.83	4.95	1.41	0.71	0.71
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	688.93	114.63	28.94	18.73	7.94	1.70	2.27	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	656.90	101.51	36.61	22.47	7.49	3.33	0.42	0.42	0.42
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	664.02	79.09	32.10	24.27	3.13	3.13	1.57	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	684.78	120.67	33.40	14.61	6.68	2.09	2.09	0.00	0.84
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	650.96	107.33	29.27	19.05	6.97	2.32	1.39	1.86	0.46
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	740.64	95.67	29.44	32.78	5.35	2.01	0.67	0.00	0.67
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	736.20	139.54	31.01	22.45	3.74	1.07	1.07	0.00	1.07
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	684.54	108.30	28.69	26.27	6.06	4.04	2.02	0.00	0.81
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	742.47	95.45	39.46	22.94	2.75	1.84	0.92	0.92	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	846.43	150.26	41.79	26.67	3.56	2.67	1.78	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	775.02	136.20	30.77	22.22	6.27	1.71	1.71	0.57	1.14
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	847.42	118.87	35.28	30.68	4.60	3.83	1.53	0.00	0.77
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	720.63	141.17	37.76	22.43	3.83	3.83	2.19	0.00	0.55
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	792.45	166.60	44.10	28.95	8.91	1.34	2.67	0.89	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	1014.34	230.84	50.69	40.29	5.46	2.34	1.82	1.04	1.56
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	889.89	181.69	41.78	25.86	2.65	1.33	1.99	0.66	1.33
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	956.16	266.06	51.97	49.89	10.39	2.08	0.00	0.00	2.08
Macrophage - monocyte derived, donor1	11232-116C8	218.34	14.59	22.79	2.73	0.68	2.73	0.68	0.23	0.23
Macrophage - monocyte derived, donor2	11313-117C8	277.28	37.99	30.46	12.85	2.75	1.28	1.47	0.18	0.37
Macrophage - monocyte derived, donor3	11389-118C3	271.08	22.55	42.99	7.34	2.23	1.18	1.18	0.52	0.39
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	683.96	137.53	156.12	50.45	24.96	2.12	1.59	3.72	2.66
Mallassez-derived cells, donor2	11929-125I3	551.57	60.21	90.48	22.50	4.44	1.27	1.11	1.58	2.06
Mallassez-derived cells, donor3	11930-125I4	667.00	117.72	109.38	45.87	11.40	1.67	1.39	3.61	3.47
Mammary Epithelial Cell, donor1	11273-116H4	529.31	140.90	93.66	39.36	6.58	0.90	0.70	1.59	2.19
Mammary Epithelial Cell, donor2	11350-117G9	558.83	145.93	91.50	55.30	11.29	1.45	1.16	4.05	0.87
Mammary Epithelial Cell, donor3	11422-118F9	846.80	196.55	76.08	44.65	18.21	1.25	1.75	1.50	1.75
Mast cell - stimulated, donor1	11487-119E2	258.29	27.12	10.17	6.78	0.00	1.36	2.03	0.00	0.00
Mast cell, donor1	11563-120D6	287.55	16.44	11.79	2.60	0.97	1.19	4.65	0.00	0.22
Mast cell, donor2	11565-120D8	392.86	35.36	12.48	7.13	2.38	2.38	8.02	0.00	0.00
Mast cell, donor3	11566-120D9	339.71	25.44	8.33	3.38	3.60	4.50	9.68	0.23	0.23
Mast cell, donor4	11567-120E1	325.86	32.62	9.57	4.79	1.60	2.66	6.74	0.00	0.18
Mast cell, expanded and stimulated, donor5	11940-126A5	440.91	25.51	18.41	5.43	0.22	1.55	2.11	0.44	0.11
Mast cell, expanded and stimulated, donor8	11942-126A7	458.19	28.60	23.93	9.92	0.00	0.58	2.33	1.75	0.00
Mast cell, expanded, donor5	11939-126A4	456.82	18.47	9.29	4.13	0.23	1.72	4.93	0.11	0.11
Mast cell, expanded, donor8	11941-126A6	288.88	12.89	9.21	3.51	0.00	1.00	4.52	0.17	0.17
Melanocyte - dark, donor1	11502-119F8	556.99	87.76	54.92	23.38	18.90	2.89	3.68	1.89	1.49
Melanocyte - dark, donor2	11582-120F7	564.81	80.98	35.65	24.57	3.46	0.00	2.77	0.69	0.35
Melanocyte - dark, donor3	11663-122F7	554.32	111.05	45.49	21.08	7.97	1.96	1.81	0.80	0.51
Melanocyte - light, donor1	11274-116H5	408.79	72.64	31.97	19.98	3.76	0.47	0.24	1.18	0.94
Melanocyte - light, donor2	11351-117H1	487.28	66.88	55.96	15.70	3.41	1.36	0.00	4.09	0.00
Melanocyte - light, donor3	11423-118G1	462.23	95.39	38.16	19.08	11.27	1.73	0.87	0.87	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	481.37	94.34	28.53	20.30	6.46	0.94	0.31	1.04	1.04
Melanocyte, donor2 (MC+2)	12739-135I3	386.47	79.88	37.65	18.56	2.96	0.54	0.54	2.15	0.81
Melanocyte, donor3 (MC+3)	12837-137B2	379.82	43.66	44.20	8.57	3.48	1.34	0.80	2.14	0.54
Meningeal Cells, donor1	11493-119E8	1093.83	133.24	67.86	38.58	10.17	1.24	1.49	5.09	1.86
Meningeal Cells, donor2	11573-120E7	793.15	77.47	50.62	23.33	13.64	1.76	2.20	2.20	2.64
Meningeal Cells, donor3	11654-122E7	818.36	117.04	46.29	47.68	6.28	1.39	1.39	3.02	0.90
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	696.64	133.74	69.01	37.07	14.83	2.57	1.14	1.14	2.57
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	279.96	47.40	31.30	10.16	0.81	0.40	0.40	0.40	0.60
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	594.00	68.34	98.56	13.14	3.94	0.00	3.94	5.26	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	1003.36	234.16	102.04	90.26	19.62	0.00	0.00	2.62	3.92
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	897.01	234.66	70.33	85.40	21.53	0.00	0.72	3.59	2.15
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	302.62	26.05	28.38	5.29	0.21	0.21	1.27	0.21	1.06
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	403.12	38.70	50.77	12.57	1.01	1.51	1.01	0.50	0.50
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	826.93	167.45	79.99	67.68	13.62	1.98	1.10	2.64	1.98
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	862.09	188.49	84.02	64.29	8.04	0.00	2.19	1.46	1.46
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	771.76	158.57	81.84	57.49	12.89	1.23	1.43	3.27	2.66
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	381.17	30.75	86.01	10.39	1.66	0.42	1.25	0.00	2.08
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	641.60	60.59	55.76	11.52	2.97	1.12	2.97	0.74	0.74
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	401.96	33.16	39.60	7.63	2.24	1.18	1.18	0.92	0.39
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	314.84	27.00	32.05	6.83	0.30	1.19	0.59	1.78	0.89
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	369.02	21.02	32.70	4.67	0.00	4.67	0.00	2.34	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	704.44	132.56	69.16	45.47	12.81	0.64	1.92	3.20	1.92
Mesenchymal stem cells - adipose, donor0	11217-116B2	983.58	275.40	94.28	93.22	19.14	2.13	2.84	3.19	2.48
Mesenchymal stem cells - hepatic, donor0	11218-116B3	384.02	39.40	45.66	6.57	1.88	1.56	1.56	1.56	1.25
Mesenchymal stem cells - umbilical, donor0	11214-116A8	816.40	199.57	73.29	71.12	26.85	0.73	2.18	2.90	1.45
Mesothelial Cells, donor1	11247-116E5	326.96	47.73	55.16	7.42	1.86	1.59	1.06	0.27	1.59
Mesothelial Cells, donor2	12156-128G5	426.90	67.56	68.56	17.02	3.50	0.00	0.00	1.00	0.50
Mesothelial Cells, donor3	11402-118D7	300.26	37.72	41.48	6.65	1.52	0.65	0.51	0.72	0.94
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	70.22	13.50	14.85	1.35	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	208.10	22.90	19.70	3.45	1.48	2.71	1.97	0.00	0.49
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	204.35	24.15	17.67	4.71	1.18	0.88	1.18	0.00	0.29
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	269.65	13.83	13.83	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	169.54	21.08	17.98	2.48	0.93	1.86	3.10	0.31	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	202.66	24.06	20.74	6.22	0.62	1.45	1.87	0.00	0.21
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	180.65	11.58	11.58	2.32	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	200.46	22.27	16.77	3.50	1.50	0.50	1.75	0.25	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	201.09	19.55	16.76	2.79	0.00	1.86	0.93	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	233.59	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	192.04	19.31	15.44	3.45	1.02	1.02	2.03	0.20	0.61
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	198.38	20.59	17.42	5.54	0.40	0.00	2.38	0.00	0.40
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	222.34	8.55	51.31	8.55	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	253.98	25.66	16.81	7.08	1.77	0.88	3.54	0.00	1.77
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	294.83	28.50	24.32	9.88	0.00	2.66	1.52	0.00	1.14
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	139.49	21.05	9.21	3.95	0.00	0.00	1.32	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	213.50	24.83	17.19	4.88	0.64	2.55	2.55	0.00	0.21
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	145.49	12.89	7.37	5.52	0.92	1.84	0.92	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	166.91	19.67	8.94	4.77	0.00	0.89	0.89	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	130.78	8.38	15.09	3.35	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	305.54	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	202.23	24.09	14.30	4.01	1.00	2.26	2.51	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	181.34	22.34	19.96	5.94	0.24	1.43	2.61	0.00	0.48
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	165.86	18.80	14.37	2.76	0.55	1.11	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	212.29	25.56	14.04	6.22	0.46	1.38	2.07	0.23	0.46
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	188.04	21.66	15.57	7.99	0.63	1.26	0.84	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	181.00	25.68	13.45	3.26	0.61	1.22	2.24	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	204.03	22.10	12.23	4.93	0.86	2.15	1.72	0.21	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	158.49	19.56	16.00	4.67	0.44	0.22	0.67	0.00	0.44
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	185.73	20.64	20.64	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	176.53	25.62	12.70	5.48	0.44	1.97	1.75	0.00	0.22
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	139.92	16.73	18.25	3.55	0.00	1.01	0.00	0.00	0.51
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	152.44	19.88	14.91	1.66	3.31	0.00	0.00	0.00	1.66
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	146.50	23.10	11.42	4.35	0.54	0.82	1.36	0.00	0.54
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	199.09	23.23	15.88	4.41	0.88	0.29	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	136.29	17.45	15.26	5.45	2.18	0.00	1.09	2.18	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	326.78	53.82	20.18	10.57	2.40	2.40	4.81	0.96	0.96
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	208.52	28.82	19.61	9.21	0.40	1.20	0.00	0.00	0.40
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	202.94	21.94	31.54	2.74	0.00	0.00	1.37	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	378.94	54.56	28.53	11.51	3.00	5.51	3.50	1.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	242.52	53.89	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	148.81	20.39	20.39	2.04	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	297.35	45.11	28.03	9.63	2.19	1.75	1.31	0.44	0.44
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	156.72	30.90	30.90	8.83	1.10	0.00	1.10	1.10	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	206.85	27.54	30.10	7.68	1.92	0.64	0.00	0.64	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	309.40	54.54	28.51	7.19	1.24	0.99	1.24	0.50	0.50
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	156.58	31.32	19.49	4.18	0.70	0.00	0.00	0.00	2.09
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	302.75	28.73	53.04	4.42	2.21	2.21	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	352.82	58.46	31.11	6.84	1.37	2.05	0.68	0.34	0.34
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	164.54	24.94	28.88	5.25	0.44	0.44	0.44	0.44	0.88
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	221.22	27.70	33.73	2.84	1.07	0.36	0.36	0.36	1.42
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	361.35	64.53	40.12	9.26	1.40	4.21	3.09	0.84	0.56
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	196.59	34.50	26.18	7.48	0.83	0.42	0.42	0.42	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	209.21	30.89	47.79	2.33	2.33	1.75	0.58	0.00	1.17
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	289.90	45.25	30.47	9.35	2.41	2.41	0.90	0.30	0.30
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	279.65	51.34	29.63	8.35	2.50	1.25	1.25	0.00	1.25
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	238.22	7.22	50.53	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	170.86	32.32	17.55	5.54	2.77	1.85	1.85	3.69	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	266.92	35.85	29.59	12.52	1.14	0.57	0.00	1.14	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	192.35	24.87	23.08	3.59	1.24	0.83	0.55	0.55	0.14
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	296.98	41.72	32.91	7.77	0.78	2.59	1.55	0.52	0.52
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	240.23	30.89	35.18	4.72	0.43	0.00	0.00	0.43	0.43
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	195.00	15.88	26.04	3.18	0.64	1.27	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	170.54	21.08	17.61	4.00	0.27	0.80	0.53	0.80	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	192.77	26.04	19.46	4.19	1.80	1.20	2.10	0.60	0.60
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	155.38	14.41	16.95	2.12	0.71	1.41	0.57	0.57	0.42
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	279.97	34.72	28.03	10.51	0.32	2.87	1.27	2.23	0.64
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	262.48	43.56	29.85	8.62	1.55	1.33	1.11	0.44	0.66
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	181.26	17.06	23.13	7.58	1.14	1.14	0.38	0.76	0.38
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	245.47	35.23	22.73	4.83	1.14	2.84	2.56	1.70	0.85
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	298.65	37.85	34.90	8.60	2.95	2.21	1.47	0.49	0.25
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	162.27	5.87	17.60	0.65	0.65	1.30	0.00	0.00	1.30
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	185.83	22.93	12.64	4.41	0.59	2.06	2.06	0.88	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	225.76	20.18	15.86	4.32	0.86	2.88	2.59	0.29	0.29
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	185.46	9.89	7.42	2.06	1.24	0.41	1.24	0.00	0.41
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	194.45	11.32	9.23	4.47	0.30	2.38	0.89	0.30	0.60
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	267.45	18.83	26.37	3.77	0.00	15.07	3.77	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	269.12	37.43	19.60	7.13	1.78	3.56	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	276.33	16.76	18.07	4.27	0.66	3.94	1.64	0.00	0.33
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	301.91	24.19	25.25	10.52	1.05	3.16	3.16	1.05	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	215.08	16.41	11.27	4.74	0.40	2.97	3.95	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	195.58	13.04	8.38	5.59	0.93	3.73	0.93	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	186.64	16.15	17.27	3.76	0.38	3.76	3.38	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	252.76	23.70	21.57	5.33	1.33	2.13	2.40	0.27	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	261.15	16.74	17.87	2.60	0.34	5.66	2.71	0.23	0.34
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	243.86	21.37	15.47	2.21	0.00	5.89	2.21	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	234.51	17.22	24.18	2.56	0.37	6.60	2.56	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	227.12	10.89	9.33	4.67	1.56	1.56	1.56	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	438.77	34.74	24.05	9.09	0.53	8.02	2.14	0.00	0.53
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	293.66	23.18	15.46	3.86	3.86	7.73	3.86	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	308.03	21.21	24.24	6.06	1.01	8.08	3.03	1.01	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	275.75	32.04	21.93	7.59	2.53	2.95	2.11	0.84	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	539.33	27.24	32.69	2.72	0.00	12.26	8.17	0.00	1.36
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	419.62	43.23	27.34	10.81	0.64	8.90	5.09	0.00	0.64
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	610.62	45.35	51.83	9.72	0.00	13.77	7.29	0.81	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	314.17	19.64	37.76	7.55	0.00	0.00	6.04	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	125.62	11.42	39.97	5.71	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	362.13	55.46	55.46	6.52	0.00	3.26	3.26	6.52	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	408.71	57.03	71.29	14.26	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	125.49	25.10	87.84	0.00	0.00	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	607.53	91.13	57.31	19.82	3.02	0.65	1.51	1.51	0.65
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	328.72	19.34	33.97	3.66	1.05	1.05	1.57	0.52	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	137.50	9.34	28.70	5.34	0.00	0.00	1.33	0.00	0.67
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	142.74	15.03	38.82	3.34	1.67	0.00	0.00	0.83	0.83
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	341.11	36.13	39.74	8.18	3.23	1.33	0.00	0.57	0.76
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	386.20	23.94	70.22	7.98	4.79	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	63.23	6.12	21.76	2.04	0.00	0.00	0.68	0.68	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	398.77	53.29	29.40	20.21	9.19	0.00	1.84	5.51	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	75.34	4.60	26.79	1.67	0.00	0.42	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	154.11	13.95	53.93	4.42	2.09	0.70	0.23	0.46	0.70
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	94.85	4.05	17.29	2.16	0.00	0.27	0.54	0.54	0.54
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	241.77	15.14	22.07	3.99	1.47	0.84	0.42	0.00	0.42
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	645.81	77.94	33.40	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	149.40	18.37	34.25	3.47	0.50	0.00	0.50	0.00	1.49
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	111.25	4.33	13.26	1.35	0.27	0.27	0.27	0.27	0.27
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	75.71	4.99	25.62	0.91	0.45	0.23	0.23	0.23	0.68
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	85.90	6.21	16.98	1.14	0.33	0.16	0.33	0.33	0.16
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	212.33	9.66	18.41	2.37	0.18	0.36	0.55	0.18	0.55
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	84.34	5.83	16.44	1.06	0.53	0.00	2.12	0.00	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	69.64	5.40	15.01	0.60	1.80	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	134.55	5.58	12.47	1.31	0.00	0.66	0.98	0.66	0.33
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	43.58	2.44	21.14	0.65	0.16	0.33	0.16	0.16	0.81
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	166.50	5.64	17.81	1.76	0.53	0.18	0.18	0.00	0.18
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	67.51	4.22	19.69	1.41	0.00	0.00	0.70	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	77.69	3.68	17.47	0.46	0.46	0.00	0.46	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	81.30	4.50	24.42	0.32	0.00	0.32	0.00	0.00	0.32
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	162.44	13.11	21.38	2.07	1.72	0.00	0.34	0.00	0.34
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	389.38	32.87	32.87	12.64	5.06	0.00	5.06	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	166.20	9.58	19.61	1.34	0.00	0.00	0.89	0.00	0.45
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	87.64	4.66	29.21	2.96	0.42	0.00	0.85	0.00	0.85
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	103.01	3.09	19.70	0.95	0.71	0.00	1.19	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	83.70	4.72	23.18	1.72	0.00	0.43	0.43	0.43	0.86
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	343.05	45.14	27.08	0.00	9.03	0.00	9.03	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	109.96	7.66	21.33	1.00	0.33	0.67	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	174.48	12.17	17.58	1.35	0.00	0.45	0.45	0.00	0.45
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	93.25	5.95	27.38	0.79	0.79	0.40	0.00	0.00	1.19
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	85.44	8.36	17.64	0.00	0.00	1.86	0.93	0.00	1.86
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	150.97	9.08	21.95	1.51	0.76	0.76	0.00	0.38	0.38
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	101.35	10.75	32.26	0.00	0.33	0.33	0.65	0.65	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	72.34	3.92	17.43	0.00	0.44	0.87	0.00	0.00	0.87
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	203.98	13.12	16.28	1.36	0.45	1.36	0.45	0.00	0.45
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	95.25	8.82	14.99	0.88	0.88	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	71.80	5.98	19.95	1.33	0.00	0.00	0.66	0.00	0.66
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	98.22	3.97	12.90	0.00	0.00	0.50	0.50	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	68.91	5.36	25.27	1.15	0.77	0.38	0.38	0.00	0.77
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	169.07	9.68	13.61	0.91	0.60	0.00	1.21	0.00	0.30
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	244.45	19.45	17.24	3.32	0.22	0.00	0.88	0.22	0.66
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	84.03	4.07	22.36	2.71	0.68	0.68	0.00	1.36	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	245.26	15.33	15.33	0.00	5.11	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	84.14	3.05	12.80	0.61	0.61	0.00	0.00	0.61	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	80.26	2.20	21.40	0.63	0.00	0.00	0.31	0.63	0.31
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	64.16	1.82	9.99	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	81.49	5.54	14.24	0.79	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	226.73	23.81	14.74	3.40	1.13	1.13	0.00	0.00	1.13
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	187.14	0.00	20.23	10.12	0.00	5.06	5.06	0.00	0.00
Myoblast, donor1	11241-116D8	546.85	140.13	85.84	37.89	10.19	0.87	0.37	1.99	1.86
Myoblast, donor2	11322-117D8	422.13	85.73	66.36	18.99	4.03	0.38	0.19	1.53	0.58
Myoblast, donor3	11398-118D3	525.68	89.97	72.14	17.83	6.22	0.67	0.84	0.00	1.51
NK T cell leukemia cell line:KHYG-1	10777-110G3	468.44	38.23	54.87	6.42	4.38	6.86	7.30	2.77	1.02
Natural Killer Cells, donor1	11230-116C6	352.72	25.52	21.83	1.23	0.31	2.46	2.15	0.62	0.62
Natural Killer Cells, donor2	11311-117C6	337.74	23.22	20.51	4.22	1.51	3.32	0.60	0.30	0.00
Natural Killer Cells, donor3	11387-118C1	358.54	21.35	21.90	3.31	2.02	3.50	2.94	0.00	0.37
Neural stem cells, donor1	11275-116H6	319.75	25.41	9.44	14.15	0.73	1.81	2.90	0.00	0.00
Neural stem cells, donor2	11352-117H2	306.18	25.03	3.85	3.85	0.00	1.93	3.85	0.00	0.00
Neurons, donor1	11494-119E9	509.78	27.31	5.69	3.41	5.69	7.97	11.38	1.14	0.00
Neurons, donor2	11574-120E8	548.87	42.93	10.79	5.94	1.54	5.28	7.05	0.22	0.44
Neurons, donor3	11655-122E8	311.60	23.84	5.76	4.93	0.82	3.29	9.04	0.00	0.82
Neutrophils, donor1	11233-116C9	131.78	10.21	1.86	0.93	0.93	0.00	0.00	0.00	0.00
Neutrophils, donor2	11314-117C9	139.15	8.70	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Neutrophils, donor3	11390-118C4	177.76	7.94	6.11	1.22	0.61	2.44	0.00	0.00	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	242.46	16.15	23.15	3.68	0.71	1.31	2.14	0.24	0.59
Nucleus Pulposus Cell, donor2	11409-118E5	218.81	19.86	21.16	4.56	0.65	0.33	1.30	0.65	0.33
Nucleus Pulposus Cell, donor3	11462-119B4	399.10	40.91	66.38	7.02	2.41	0.40	0.60	0.40	1.00
Olfactory epithelial cells, donor1	11933-125I7	190.37	12.66	27.53	2.06	0.55	0.69	1.10	0.28	0.28
Olfactory epithelial cells, donor2	11934-125I8	295.86	28.37	51.82	6.22	1.30	0.72	2.03	0.87	0.72
Olfactory epithelial cells, donor3	11935-125I9	224.51	17.82	48.58	4.99	0.45	0.45	0.57	0.34	0.79
Olfactory epithelial cells, donor4	11936-126A1	270.08	18.80	40.13	4.97	0.68	0.29	0.10	0.39	0.68
Oligodendrocyte - precursors, donor1	11496-119F2	603.63	107.73	58.98	25.88	12.64	0.00	1.20	0.60	1.20
Osteoblast - differentiated, donor1	11276-116H7	419.43	48.28	57.21	11.70	1.06	1.28	1.06	0.00	1.06
Osteoblast - differentiated, donor2	11353-117H3	228.62	20.58	32.01	2.29	0.00	2.29	0.00	0.00	1.14
Osteoblast - differentiated, donor3	11425-118G3	245.80	29.79	28.55	4.97	1.24	1.86	1.86	0.00	0.00
Osteoblast, donor1	11277-116H8	1062.00	164.75	56.48	35.76	4.69	1.76	6.45	1.76	1.37
Osteoblast, donor2	11354-117H4	696.00	108.16	47.06	35.82	2.81	1.40	2.11	0.70	2.11
Osteoblast, donor3	11426-118G4	729.05	106.99	70.38	16.53	9.60	1.07	1.78	1.60	1.24
Pancreatic stromal cells, donor1	11249-116E7	513.50	76.65	62.17	19.37	3.45	0.51	1.01	1.10	1.35
Pericytes, donor1	11491-119E6	526.51	29.60	32.16	6.01	3.12	2.11	5.34	0.45	1.00
Pericytes, donor2	11571-120E5	483.97	33.95	31.01	5.43	3.62	0.91	5.66	1.13	0.68
Pericytes, donor3	11652-122E5	734.66	122.48	83.62	26.25	4.48	1.42	1.02	2.44	2.64
Perineurial Cells, donor1	11499-119F5	605.79	68.72	73.24	19.21	10.62	0.79	1.13	1.92	1.13
Perineurial Cells, donor2	11579-120F4	665.42	83.09	47.75	21.99	7.54	1.10	1.75	1.66	1.01
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	304.08	16.26	19.12	4.14	1.27	2.87	3.19	0.32	0.00
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	247.80	15.43	21.55	2.69	0.49	5.39	3.67	0.00	0.24
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	251.84	16.57	17.60	2.98	0.91	4.92	3.62	0.00	0.39
Placental Epithelial Cells, donor1	11278-116H9	573.04	38.98	42.57	9.81	2.63	6.46	1.20	1.43	1.20
Placental Epithelial Cells, donor2	11355-117H5	440.23	35.48	45.46	15.52	2.22	1.11	2.22	2.22	2.22
Placental Epithelial Cells, donor3	11427-118G5	435.26	38.87	33.77	4.91	3.93	2.94	3.14	0.79	1.37
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	382.27	53.16	61.39	10.76	1.27	0.00	0.00	0.63	0.95
Preadipocyte - breast, donor1	11467-119B9	335.41	22.89	42.58	8.25	0.19	0.56	0.56	0.56	1.13
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	304.91	49.73	10.18	9.79	5.09	0.65	0.39	0.26	0.13
Preadipocyte - breast, donor2	11328-117E5	432.06	49.53	56.06	7.88	3.38	1.80	0.68	0.68	0.90
Preadipocyte - omental, donor1	11468-119C1	296.66	23.12	48.59	6.50	1.07	0.32	0.43	0.53	0.96
Preadipocyte - omental, donor2	11329-117E6	335.65	29.68	49.76	6.55	2.18	0.44	0.00	0.44	0.44
Preadipocyte - omental, donor3	11403-118D8	446.51	63.03	63.03	11.60	3.87	0.57	0.57	0.43	1.00
Preadipocyte - perirenal, donor1	11469-119C2	435.05	38.39	111.22	6.89	4.92	1.97	0.98	1.97	6.89
Preadipocyte - subcutaneous, donor1	11279-116I1	839.35	199.93	56.51	54.67	6.14	1.23	1.54	1.54	4.61
Preadipocyte - subcutaneous, donor2	11356-117H6	768.69	202.75	63.92	55.25	14.17	1.06	0.35	1.95	1.42
Preadipocyte - subcutaneous, donor3	11428-118G6	748.74	138.27	85.99	29.63	8.00	0.85	0.17	0.51	1.19
Preadipocyte - visceral, donor1	11280-116I2	546.87	113.27	61.57	44.06	5.40	1.02	0.56	2.42	1.49
Preadipocyte - visceral, donor2	11357-117H7	498.84	75.01	43.26	22.55	5.06	0.00	0.46	0.92	0.92
Preadipocyte - visceral, donor3	11429-118G7	559.65	115.46	70.11	31.56	10.03	0.52	1.36	1.25	1.15
Prostate Epithelial Cells (polarized), donor1	11253-116F2	175.74	29.27	13.88	3.17	2.56	1.81	0.60	0.45	0.45
Prostate Epithelial Cells, donor2	11331-117E8	316.06	73.26	66.22	24.78	8.26	0.14	0.14	2.03	1.49
Prostate Epithelial Cells, donor3	11404-118D9	169.26	40.72	41.89	8.45	3.25	0.06	0.00	0.37	0.92
Prostate Stromal Cells, donor1	11254-116F3	679.76	137.02	53.19	36.45	8.31	0.46	0.57	1.37	1.14
Prostate Stromal Cells, donor2	11332-117E9	512.08	103.10	54.69	32.09	5.92	0.18	0.72	1.08	1.43
Prostate Stromal Cells, donor3	11405-118E1	307.41	36.50	41.61	10.11	1.67	0.42	0.83	0.63	0.94
Renal Cortical Epithelial Cells, donor1	11516-119H4	606.24	89.79	80.30	28.47	6.20	2.19	2.19	4.01	2.92
Renal Cortical Epithelial Cells, donor2	11596-120H3	479.50	67.58	45.68	20.86	3.26	0.69	0.83	1.73	0.62
Renal Epithelial Cells, donor1	11517-119H5	1041.85	172.46	95.87	61.88	16.23	3.04	3.55	5.58	2.03
Renal Epithelial Cells, donor2	11597-120H4	766.09	110.25	74.69	42.68	11.38	2.13	0.71	3.56	2.13
Renal Epithelial Cells, donor3	11678-122H4	369.36	49.65	44.36	20.11	2.43	0.74	0.53	1.16	0.74
Renal Glomerular Endothelial Cells, donor1	11514-119H2	650.21	72.85	61.96	18.38	18.38	0.68	3.40	1.36	2.72
Renal Glomerular Endothelial Cells, donor2	11594-120H1	637.17	106.19	57.68	28.17	18.87	0.67	0.40	3.37	1.08
Renal Glomerular Endothelial Cells, donor3	11675-122H1	661.59	104.12	37.74	42.63	20.65	1.78	0.89	1.55	0.89
Renal Glomerular Endothelial Cells, donor4	11783-124B1	860.42	101.15	66.54	34.60	9.32	1.33	0.67	4.66	2.00
Renal Mesangial Cells, donor1	11518-119H6	783.95	112.69	58.10	38.30	10.78	2.42	2.42	3.30	2.20
Renal Mesangial Cells, donor2	11598-120H5	710.37	68.34	53.29	21.94	8.15	0.63	0.63	1.88	1.25
Renal Mesangial Cells, donor3	11679-122H5	570.91	72.68	39.67	18.59	5.83	1.11	2.22	1.11	0.83
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	893.31	174.74	112.47	60.40	20.40	1.88	1.34	5.64	2.68
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	655.31	124.82	86.03	33.74	6.33	0.42	0.00	6.33	0.84
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	783.73	119.37	64.99	41.65	12.34	1.16	1.16	1.93	1.54
Retinal Pigment Epithelial Cells, donor0	11215-116A9	582.09	73.38	41.74	17.11	6.48	1.30	1.30	2.85	2.33
Retinal Pigment Epithelial Cells, donor1	11528-119I7	485.49	41.50	50.31	14.21	3.41	0.85	1.42	1.99	1.99
Retinal Pigment Epithelial Cells, donor2	11608-120I6	768.76	120.41	37.05	50.43	7.20	1.03	2.06	5.15	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	460.67	33.87	25.84	16.06	0.75	0.25	0.25	2.01	0.75
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	260.99	21.25	8.69	2.54	1.60	3.21	0.40	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	379.70	25.02	13.40	5.36	0.89	2.68	0.89	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	199.78	14.31	4.95	3.85	0.00	4.95	3.85	0.00	0.55
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	237.82	15.08	9.28	4.64	0.58	1.74	0.58	0.00	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	606.96	52.14	22.75	9.62	2.86	1.82	1.69	0.91	0.91
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	491.86	42.50	22.05	10.23	3.08	1.39	0.70	0.60	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	709.39	57.33	28.33	17.18	3.57	2.68	2.23	1.12	0.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	664.50	66.12	29.65	10.30	8.93	2.23	3.23	0.99	0.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	576.66	56.06	24.24	13.99	2.33	1.63	1.98	0.70	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	612.04	47.84	27.50	13.64	3.00	2.54	0.92	1.16	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	478.36	41.35	21.08	8.08	5.07	2.05	1.37	0.55	1.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	467.74	38.27	20.72	9.38	2.27	2.27	1.51	0.91	1.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	647.41	59.85	26.70	15.95	3.23	2.69	1.08	1.61	0.54
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	570.96	53.22	27.11	8.32	6.89	2.30	1.58	1.72	0.72
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	551.70	49.15	20.71	12.56	3.43	0.97	0.64	0.75	0.32
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	557.82	52.44	27.66	12.39	2.66	1.77	1.99	1.55	0.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	465.13	42.25	20.46	7.84	4.59	1.53	1.34	0.38	0.96
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	457.90	40.06	17.24	9.22	2.70	1.40	1.77	0.47	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	622.16	47.35	17.48	16.54	2.07	1.88	1.88	1.13	1.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	478.67	36.49	25.48	5.57	3.85	1.59	0.66	0.40	1.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	487.68	42.15	22.58	9.64	3.60	1.95	1.65	0.68	0.78
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	586.05	47.55	26.93	11.84	4.01	1.72	2.10	1.15	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	522.11	39.41	23.39	8.86	4.27	1.39	1.60	1.17	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	493.90	41.49	21.02	7.85	2.52	1.68	1.68	0.28	0.84
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	565.50	47.34	26.15	11.96	3.42	1.03	1.54	1.20	0.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	453.09	39.02	21.33	6.38	2.73	1.09	0.55	0.55	1.09
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	513.95	47.70	23.30	11.90	2.33	1.23	0.86	1.10	0.98
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	618.28	56.15	28.74	12.49	4.97	2.15	2.42	1.07	0.94
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	653.37	56.37	31.14	10.38	7.31	3.07	0.94	0.47	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	531.15	49.80	21.03	11.11	3.17	1.98	0.40	0.40	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	642.84	53.55	24.55	14.26	1.40	3.98	1.40	0.70	0.94
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	583.50	54.95	26.33	11.20	5.60	2.70	4.15	0.62	0.83
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	599.92	38.71	22.78	12.17	1.33	1.99	1.55	0.22	0.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	532.86	45.54	25.48	13.58	2.92	1.46	2.09	0.63	0.84
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	548.30	51.28	25.84	10.36	6.33	1.88	1.88	0.81	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	412.62	35.42	21.97	10.05	2.55	1.19	2.04	0.51	0.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	510.33	46.08	23.71	10.60	3.86	2.31	0.58	0.19	1.74
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	579.60	60.69	29.06	12.38	5.85	2.41	2.92	0.69	1.03
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	441.68	33.74	24.14	8.64	3.43	0.69	1.10	0.41	0.96
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	541.27	54.50	26.60	10.84	2.30	1.97	2.46	0.66	0.49
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	436.13	38.52	22.50	7.50	3.92	2.22	1.87	0.85	0.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	530.58	45.13	30.04	11.10	3.40	1.63	1.48	1.33	0.74
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	460.07	32.79	22.12	7.73	2.40	1.87	0.80	0.53	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	395.17	33.05	18.11	6.22	3.18	1.80	1.80	0.41	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	562.16	52.86	33.33	11.91	3.33	2.38	1.67	0.24	0.48
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	381.72	31.44	23.78	6.65	2.22	1.61	1.21	0.00	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	483.11	37.39	24.77	6.59	3.48	2.26	1.98	0.66	0.75
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	415.74	39.83	20.26	5.24	1.40	4.19	1.40	0.70	0.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	318.23	30.83	23.27	6.35	1.81	2.12	1.81	0.30	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	590.64	44.18	30.60	7.59	2.94	2.08	2.08	0.49	0.73
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	385.42	32.75	18.63	6.26	0.87	1.46	0.73	0.15	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	460.58	35.90	31.64	6.69	3.65	3.04	1.83	0.00	1.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	588.33	59.68	25.62	5.43	3.62	2.41	3.32	0.90	1.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	394.02	37.09	18.32	9.05	1.36	2.04	2.94	0.90	0.45
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	396.89	34.45	22.47	7.19	2.40	3.29	0.90	0.00	0.90
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	495.91	43.69	23.26	6.02	1.30	2.13	1.53	0.94	0.94
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	345.99	34.36	26.04	4.91	1.71	1.49	0.64	1.49	0.64
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	305.90	29.45	21.03	7.21	0.00	3.00	0.60	1.20	0.60
Schwann Cells, donor1	11498-119F4	1002.61	131.65	97.04	31.97	20.88	2.63	2.07	3.01	2.26
Schwann Cells, donor2	11578-120F3	670.28	105.47	64.65	37.43	6.80	0.00	3.40	0.00	0.00
Schwann Cells, donor3	11659-122F3	704.35	69.01	55.43	19.94	6.13	1.97	2.85	2.85	0.66
Sebocyte, donor1	11220-116B5	471.63	122.70	95.31	32.87	12.60	0.00	0.55	3.83	2.19
Sebocyte, donor2	11301-117B5	348.80	101.10	69.85	39.52	13.33	1.38	0.00	0.92	1.84
Sebocyte, donor3	11378-118B1	187.56	42.25	32.98	11.13	5.36	0.21	0.41	0.21	1.65
Sertoli Cells, donor1	11255-116F4	594.72	77.86	91.11	29.82	1.66	0.00	0.00	1.66	1.66
Sertoli Cells, donor2	11333-117F1	514.03	22.59	56.49	11.30	2.82	0.00	0.00	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	559.36	54.81	57.45	12.76	1.23	1.41	1.50	1.94	1.06
Skeletal Muscle Cells, donor2	11358-117H8	422.86	35.42	35.42	5.06	1.45	3.61	1.45	2.17	1.45
Skeletal Muscle Cells, donor3	11430-118G8	1258.24	168.88	70.23	37.62	15.05	1.67	0.84	2.51	2.51
Skeletal Muscle Cells, donor4	11451-119A2	697.81	174.06	60.01	55.93	18.69	1.41	1.10	2.98	2.20
Skeletal Muscle Cells, donor5	11455-119A6	556.97	131.85	61.09	44.00	13.08	1.04	0.74	2.23	1.34
Skeletal Muscle Cells, donor6	11459-119B1	728.11	164.68	70.18	49.86	21.08	0.92	0.92	3.85	1.23
Skeletal Muscle Satellite Cells, donor1	11240-116D7	499.87	78.38	57.71	29.74	6.05	0.76	2.77	1.51	0.88
Skeletal Muscle Satellite Cells, donor2	11321-117D7	475.30	72.34	50.23	30.11	6.99	0.71	1.71	1.57	0.71
Skeletal Muscle Satellite Cells, donor3	11397-118D2	752.61	179.47	66.77	57.64	27.78	1.39	0.89	2.58	1.98
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	541.57	66.31	36.65	13.06	0.93	0.84	1.94	0.59	0.51
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	1009.65	126.66	113.63	27.50	15.92	2.17	1.45	1.45	5.07
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	550.67	57.10	40.18	11.56	4.27	1.10	2.06	0.55	0.96
Skin - palm, donor1	10286-104F7	451.27	29.55	94.01	16.12	0.00	0.00	0.00	2.69	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	186.68	51.61	33.88	18.74	1.87	0.14	0.14	0.86	0.29
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	140.68	34.35	11.45	22.08	0.00	0.00	0.00	0.82	0.82
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	203.70	57.51	40.38	17.79	2.60	0.52	0.91	1.82	0.26
Small Airway Epithelial Cells, donor1	11256-116F5	352.52	82.57	82.57	29.47	3.89	0.42	0.14	1.81	1.25
Small Airway Epithelial Cells, donor2	11334-117F2	232.22	56.26	57.95	11.67	5.34	0.00	0.42	1.13	1.55
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	176.56	57.72	22.41	19.66	11.63	0.63	0.00	0.63	0.42
Small Airway Epithelial Cells, donor3	11406-118E2	195.02	51.19	60.86	10.34	4.20	0.22	0.00	0.60	1.57
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	846.75	141.95	138.25	28.70	5.25	1.23	0.31	0.93	3.09
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	289.03	47.36	22.01	11.12	3.33	0.22	0.00	0.00	0.67
Smooth Muscle Cells - Aortic, donor0	11210-116A4	616.04	107.57	105.22	22.93	5.29	1.18	0.59	1.76	2.94
Smooth Muscle Cells - Aortic, donor1	11283-116I5	1142.97	181.21	61.44	46.41	9.72	0.44	0.88	1.10	1.99
Smooth Muscle Cells - Aortic, donor2	11360-117I1	926.56	195.32	105.14	51.59	10.63	1.58	0.39	2.36	1.58
Smooth Muscle Cells - Aortic, donor3	11432-118H1	752.48	117.43	92.71	30.90	6.18	0.00	2.32	2.32	3.86
Smooth Muscle Cells - Bladder, donor1	11519-119H7	276.21	12.01	8.01	2.00	2.00	1.00	0.00	0.00	1.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	915.71	164.62	118.04	39.39	7.98	1.06	1.60	2.79	2.13
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	498.50	84.45	97.53	21.50	5.10	1.11	0.66	1.33	1.99
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	594.19	116.51	113.82	20.23	9.60	0.51	0.38	2.30	5.25
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	444.43	47.54	32.88	9.12	4.23	0.65	1.30	1.30	1.30
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	472.52	59.95	75.90	15.36	5.61	0.89	0.30	0.89	1.48
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	350.79	45.84	58.08	11.96	5.13	0.43	0.57	1.14	1.28
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	774.66	134.21	115.01	56.29	9.27	1.46	0.65	2.28	3.74
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	266.99	27.09	31.36	7.00	2.44	1.83	1.22	0.30	0.91
Smooth Muscle Cells - Carotid, donor1	11285-116I7	767.03	87.39	79.56	20.21	3.28	2.02	1.26	1.52	2.27
Smooth Muscle Cells - Carotid, donor2	11362-117I3	2613.54	1046.64	318.28	257.07	30.60	0.00	0.00	0.00	12.24
Smooth Muscle Cells - Carotid, donor3	11434-118H3	890.73	138.76	68.66	28.13	8.58	0.48	1.43	2.38	0.95
Smooth Muscle Cells - Colonic, donor1	11239-116D6	378.71	46.60	38.49	14.01	1.92	0.88	0.59	0.59	1.47
Smooth Muscle Cells - Colonic, donor2	11320-117D6	415.41	51.87	39.17	15.71	5.60	0.00	1.08	0.86	1.08
Smooth Muscle Cells - Colonic, donor3	11396-118D1	476.82	75.25	59.51	21.31	11.65	0.63	0.94	1.89	1.36
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	856.92	191.03	96.36	48.88	9.59	1.08	0.46	2.78	1.70
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	770.68	159.53	153.06	35.57	11.86	0.00	1.08	4.31	1.08
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	614.15	103.70	74.12	19.13	4.18	0.60	0.90	2.99	1.79
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	974.69	157.39	86.72	53.94	10.58	1.02	2.05	2.39	0.68
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	363.28	26.46	25.29	5.10	1.33	0.71	2.12	0.86	0.47
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	411.02	60.28	95.21	18.82	2.62	0.40	0.30	0.60	1.71
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	557.05	101.03	80.10	17.29	3.87	1.37	0.68	3.64	0.91
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	784.95	127.40	84.53	13.89	6.04	0.60	0.00	1.81	3.62
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	782.33	238.70	61.20	91.93	45.57	2.38	2.38	3.18	1.85
Smooth Muscle Cells - Prostate, donor1	11257-116F6	488.83	81.49	47.80	13.72	5.99	0.80	0.67	1.07	0.93
Smooth Muscle Cells - Prostate, donor2	11335-117F3	423.99	62.61	48.96	18.28	6.01	0.38	0.75	0.88	1.00
Smooth Muscle Cells - Prostate, donor3	11465-119B7	266.09	23.84	36.53	4.57	2.03	2.03	1.27	0.51	0.51
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	791.71	118.21	85.34	30.46	4.37	1.36	0.60	0.75	1.96
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	603.13	68.27	68.27	14.25	5.25	0.00	0.00	0.00	2.25
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	3906.37	326.93	89.16	100.79	36.18	0.00	1.29	0.00	1.29
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	991.99	160.91	86.04	38.14	4.65	0.47	0.00	0.93	0.47
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	681.59	92.39	84.82	20.20	6.06	1.01	0.00	2.02	2.02
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	518.98	81.80	91.51	19.43	4.70	0.63	0.31	1.88	2.82
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	529.52	91.45	105.31	32.15	5.01	0.59	2.06	2.95	4.42
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	757.18	149.87	73.48	42.15	13.83	1.17	2.50	1.58	1.92
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	277.03	16.82	27.56	5.61	1.40	1.40	1.87	0.47	0.93
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	789.10	132.12	96.71	27.49	4.61	0.58	0.43	2.30	3.45
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	953.53	184.84	87.45	35.18	16.57	2.80	0.76	3.06	2.55
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	771.69	121.66	72.77	18.24	9.59	1.50	1.32	1.50	2.07
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	570.86	89.30	73.51	23.20	13.69	1.26	1.82	1.82	1.26
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	595.73	79.43	72.06	17.51	8.55	0.84	1.26	1.34	1.09
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	423.33	40.00	70.47	12.38	0.95	0.00	0.00	1.43	3.33
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	757.47	140.44	106.18	26.67	6.12	0.98	0.24	2.20	4.65
Smooth Muscle Cells - Uterine, donor1	11258-116F7	423.12	74.46	56.34	12.37	3.98	0.22	0.44	1.33	1.33
Smooth Muscle Cells - Uterine, donor3	11466-119B8	565.85	124.93	55.59	24.28	7.90	1.17	0.59	1.46	1.46
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	192.42	9.33	15.94	2.72	0.00	0.19	0.39	0.39	0.78
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	287.73	27.77	35.44	7.14	0.26	0.26	0.00	0.53	0.79
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	143.94	11.90	8.55	6.32	0.00	0.00	1.12	0.37	0.37
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	297.89	34.50	50.31	11.50	1.08	1.08	0.00	1.44	2.16
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	389.79	59.90	55.08	17.03	0.57	0.28	0.28	0.57	1.14
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	530.15	82.32	39.78	21.66	1.18	1.58	0.39	0.39	0.79
Smooth muscle cells - airway, control, donor1	11966-126D4	243.29	24.13	36.57	7.62	0.51	0.25	0.25	0.51	1.02
Smooth muscle cells - airway, control, donor2	11967-126D5	196.86	12.78	23.16	5.19	0.00	1.60	0.80	0.00	0.40
Smooth muscle cells - airway, control, donor3	11968-126D6	227.39	23.41	20.48	3.76	0.00	0.00	1.25	0.00	0.00
Smooth muscle cells - airway, control, donor4	11969-126D7	251.64	16.96	16.50	2.29	0.46	1.38	0.92	0.46	0.00
Synoviocyte, donor1	11291-117A4	396.40	44.94	38.04	11.95	1.01	0.84	0.34	1.01	0.50
Synoviocyte, donor2	11368-117I9	281.94	27.83	36.71	6.20	2.01	0.17	1.34	0.17	0.00
Synoviocyte, donor3	11440-118H9	250.22	16.31	25.02	2.23	1.34	0.45	0.22	0.00	0.45
Trabecular Meshwork Cells, donor1	11532-120A2	1067.35	185.81	72.54	65.03	12.51	2.86	3.22	3.57	2.86
Trabecular Meshwork Cells, donor2	11612-122A1	584.70	95.14	87.21	37.66	3.96	0.00	0.00	9.91	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	630.97	92.39	48.16	26.16	6.48	1.85	1.62	2.32	1.85
Tracheal Epithelial Cells, donor1	11292-117A5	394.62	115.27	79.21	45.23	8.89	0.79	0.36	1.79	2.01
Tracheal Epithelial Cells, donor2	11369-118A1	560.52	172.79	89.68	57.60	27.06	0.39	0.00	1.93	1.55
Tracheal Epithelial Cells, donor3	11441-118I1	561.78	156.91	96.21	34.93	18.90	0.00	0.57	2.29	3.44
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	269.05	23.25	7.87	3.44	0.62	2.95	1.23	0.25	0.12
Urethra, donor2	10319-105A4	183.44	3.60	14.39	1.80	0.00	0.00	3.60	0.00	0.00
Urothelial Cells, donor1	11520-119H8	603.05	130.97	77.31	36.13	9.56	0.53	0.00	2.66	2.39
Urothelial Cells, donor2	11600-120H7	471.06	106.55	89.33	25.24	5.61	0.00	0.80	1.20	1.20
Urothelial Cells, donor3	11681-122H7	386.21	76.33	53.86	16.73	4.58	0.69	0.23	0.92	1.15
Urothelial cells, donor0	11216-116B1	281.52	53.94	49.04	14.71	2.90	0.45	0.45	0.89	1.78
Whole blood (ribopure), donor090309, donation1	12179-129A1	388.84	27.58	33.81	0.89	2.67	1.78	3.56	0.00	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	401.72	34.31	28.59	7.15	4.29	10.01	5.72	0.00	1.43
Whole blood (ribopure), donor090309, donation3	12181-129A3	179.34	15.06	18.48	0.68	1.37	4.11	0.00	0.00	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	206.60	15.84	20.32	2.07	0.69	5.17	1.38	0.00	0.00
Whole blood (ribopure), donor090325, donation2	12177-128I8	243.45	11.04	16.27	1.74	0.58	3.49	2.91	0.00	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	311.33	23.95	22.91	1.04	0.00	4.16	0.00	1.04	1.04
Whole blood (ribopure), donor090612, donation2	12183-129A5	350.60	23.86	27.53	1.84	1.84	6.42	0.92	0.00	0.92
Whole blood (ribopure), donor090612, donation3	12184-129A6	192.62	15.52	25.56	0.91	2.74	5.48	2.74	0.00	0.00
Wilms' tumor cell line:G-401	10809-111A8	564.25	73.89	36.14	16.16	11.84	1.48	1.85	3.21	1.73
Wilms' tumor cell line:HFWT	10597-108E3	274.57	20.24	25.52	7.92	1.76	0.88	0.00	0.00	2.64
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	532.38	107.82	120.94	43.85	23.18	0.28	0.56	0.28	3.35
achilles tendon, donor2	10292-104G4	301.71	55.80	4.13	8.27	2.07	0.00	0.00	0.00	4.13
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	380.90	62.46	22.69	11.73	5.35	10.71	5.35	3.82	0.51
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	652.18	76.62	51.08	18.34	19.73	5.57	6.04	2.79	1.86
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	248.10	23.62	12.58	3.09	2.14	1.54	1.07	0.95	0.12
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	677.84	115.10	77.55	32.93	17.14	2.99	2.72	1.63	3.27
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	469.97	48.07	32.61	17.99	5.06	3.65	3.09	1.69	1.41
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	670.61	72.12	94.74	19.88	5.71	5.50	9.09	1.06	2.33
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	237.37	21.23	21.78	7.89	1.36	3.54	1.63	1.91	1.63
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	328.28	41.42	12.78	11.90	3.08	1.32	3.08	0.00	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	291.16	16.33	29.40	6.53	0.82	1.63	3.27	1.23	1.23
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	462.85	75.72	84.26	18.64	13.59	5.82	8.93	1.55	0.00
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	278.94	49.31	30.91	34.59	6.81	3.31	1.47	1.66	0.55
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	429.06	62.41	54.61	35.10	19.50	15.60	7.80	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	804.97	59.72	48.80	25.10	4.65	3.02	4.88	2.32	0.93
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	813.47	100.97	42.72	32.88	8.28	9.58	12.95	1.29	0.78
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	813.31	110.18	77.44	52.31	13.15	13.44	9.06	3.80	1.75
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	255.15	54.38	91.09	47.41	8.37	7.44	5.11	0.46	0.93
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	542.03	25.09	35.37	7.81	1.23	6.58	2.88	1.65	1.23
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	127.08	21.18	36.83	7.37	2.15	1.84	0.92	0.92	1.53
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	184.34	44.38	27.74	25.18	8.96	4.69	2.99	0.43	0.85
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	226.86	40.03	31.24	14.25	6.37	4.85	5.46	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	246.96	46.94	35.38	20.22	8.91	4.33	3.61	1.44	1.20
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	639.04	98.23	58.13	44.10	8.24	8.46	2.67	2.45	2.00
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	631.74	86.06	23.35	20.01	2.33	0.33	1.00	0.33	1.33
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	310.32	39.02	37.16	13.01	1.86	0.00	0.00	1.86	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	462.54	86.26	28.63	37.67	6.78	5.65	4.52	2.64	0.38
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	566.97	67.60	76.32	16.14	2.62	2.62	3.49	3.49	0.87
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	416.13	56.23	119.97	20.62	3.75	7.50	1.87	1.87	5.62
adenocarcinoma cell line:IM95m	10796-110I4	383.16	19.55	84.54	4.24	3.06	1.65	0.94	0.47	0.94
adipose tissue, adult, pool1	10010-101C1	281.54	22.34	17.84	4.19	1.55	3.26	2.17	0.00	0.16
adipose, donor1	10184-103D4	412.83	17.01	12.90	6.45	4.69	5.86	2.35	0.59	0.59
adipose, donor2	10185-103D5	148.01	4.87	6.08	1.62	1.22	0.00	0.00	0.00	0.41
adipose, donor3	10186-103D6	315.04	28.86	16.61	5.72	6.81	1.36	0.27	2.18	0.27
adipose, donor4	10187-103D7	1072.17	131.75	48.54	28.60	16.47	3.47	0.00	10.40	5.20
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	302.86	43.72	25.57	12.31	7.26	0.32	1.58	0.79	2.37
adrenal gland, adult, pool1	10081-102A9	221.90	14.55	10.91	0.00	0.00	0.00	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	279.89	25.35	56.43	8.94	2.80	2.53	0.80	0.93	1.20
alveolar cell carcinoma cell line:SW 1573	10708-109H6	654.57	67.17	52.88	17.15	3.57	1.79	2.14	1.43	1.07
amniotic membrane cells, donor1	12235-129G3	261.99	23.65	30.14	3.48	1.16	0.23	0.00	0.00	0.23
amniotic membrane cells, donor2	12236-129G4	386.45	36.18	27.39	4.06	4.73	2.03	1.35	0.34	0.68
amniotic membrane cells, donor3	12237-129G5	243.05	17.97	25.63	2.95	2.65	0.59	0.00	0.00	0.59
amygdala - adult, donor10196	10167-103B5	145.85	13.04	8.30	4.74	1.19	1.19	2.37	0.00	2.37
amygdala, adult, donor10252	10151-102I7	144.17	7.91	5.07	1.62	1.82	1.62	6.29	0.00	0.61
amygdala, newborn, donor10223	10360-105E9	154.61	9.36	8.71	1.61	0.00	0.65	1.61	0.00	0.65
anaplastic carcinoma cell line:8305C	10428-106D5	104.03	9.30	11.21	1.15	0.25	0.38	0.38	0.25	0.51
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	516.70	52.73	30.67	10.37	7.06	3.75	1.76	2.21	1.10
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	285.60	20.04	20.71	4.34	1.34	1.67	0.67	0.00	0.67
aorta, adult, pool1	10052-101G7	176.72	10.40	8.04	2.16	1.57	1.57	1.77	0.00	0.39
appendix, adult	10189-103D9	245.68	24.45	22.51	6.21	0.39	2.72	2.33	0.00	0.39
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	480.48	40.24	29.23	17.20	5.50	4.13	3.44	2.41	1.38
artery, adult	10190-103E1	264.94	9.51	5.43	4.08	0.00	4.08	1.36	0.00	0.00
astrocytoma cell line:TM-31	10425-106D2	231.50	17.09	11.44	2.46	0.87	1.88	1.59	0.87	0.43
b cell line:RPMI1788	10427-106D4	404.17	73.76	41.19	23.35	6.99	4.31	2.08	4.46	1.49
basal cell carcinoma cell line:TE 354.T	10702-109G9	579.03	62.98	105.71	11.93	1.94	1.11	1.11	0.83	1.66
bile duct carcinoma cell line:HuCCT1	10432-106D9	398.81	108.66	53.59	25.50	11.41	1.59	0.69	2.68	1.49
bile duct carcinoma cell line:TFK-1	10496-107C1	213.07	30.80	34.65	4.18	1.84	1.34	0.00	0.17	0.67
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	242.71	35.79	37.47	8.39	3.91	2.24	5.03	1.12	1.68
bladder, adult, pool1	10011-101C2	197.94	17.71	14.01	3.04	1.09	2.28	0.65	0.11	0.22
blood, adult, pool1	10053-101G8	181.60	4.43	37.65	0.00	0.00	2.21	0.00	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	214.94	18.84	30.83	2.57	2.57	0.86	1.71	0.00	0.86
bone marrow, adult	10192-103E3	256.43	16.87	12.15	3.37	0.67	1.35	0.67	0.00	0.67
brain, adult, donor1	10084-102B3	175.29	20.50	5.13	1.03	1.03	0.00	5.13	0.00	0.00
brain, adult, pool1	10012-101C3	197.33	14.14	9.24	4.34	1.67	1.56	5.90	0.00	0.45
brain, fetal, pool1	10085-102B4	323.24	2.67	5.34	0.00	0.00	8.01	2.67	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	339.61	35.35	34.36	6.61	2.31	0.00	0.00	0.66	0.33
breast carcinoma cell line:MDA-MB-453	10419-106C5	164.14	13.61	23.97	3.37	1.25	1.25	0.87	0.37	0.37
breast, adult, donor1	10080-102A8	114.91	7.58	10.10	0.63	0.63	0.63	0.63	0.00	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	311.62	65.55	127.93	32.39	17.91	1.78	0.51	3.18	3.81
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	276.44	22.88	42.36	7.42	4.02	2.16	0.00	0.00	0.31
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	237.13	40.98	52.72	35.91	7.83	1.38	1.38	0.69	1.84
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	340.62	30.26	95.62	6.78	2.91	2.18	0.24	1.94	2.42
carcinoid cell line:NCI-H1770	10703-109H1	409.05	17.87	19.75	3.29	2.35	0.00	0.00	0.00	0.47
carcinoid cell line:NCI-H727	10735-110B6	349.69	37.63	23.84	7.33	2.95	1.42	0.44	0.88	0.66
carcinoid cell line:SK-PN-DW	10719-109I8	296.93	25.67	25.03	7.29	3.17	0.32	1.27	0.00	0.63
carcinosarcoma cell line:JHUCS-1	10642-109A3	366.26	19.16	23.69	5.86	2.13	2.66	2.40	1.06	1.06
caudate nucleus - adult, donor10196	10177-103C6	141.61	13.82	3.45	2.30	0.00	0.00	2.30	0.00	0.00
caudate nucleus, adult, donor10252	10164-103B2	172.51	8.03	5.19	2.34	1.00	2.51	4.69	0.00	0.33
caudate nucleus, adult, donor10258	10379-105H1	227.71	6.88	4.58	7.64	1.53	3.06	2.29	0.00	0.00
caudate nucleus, newborn, donor10223	10354-105E3	176.16	9.89	6.96	3.66	0.00	1.10	0.73	0.37	0.00
cerebellum - adult, donor10196	10173-103C2	227.24	5.83	5.83	0.00	0.00	2.91	8.74	0.00	0.00
cerebellum, adult, donor10252	10166-103B4	179.14	6.83	1.28	1.07	1.07	4.06	6.19	0.00	0.00
cerebellum, adult, pool1	10083-102B2	185.24	7.24	8.28	0.69	1.38	1.38	4.83	0.00	0.00
cerebellum, newborn, donor10223	10357-105E6	268.18	1.66	2.49	1.66	0.00	3.32	0.83	0.00	0.00
cerebral meninges, adult	10188-103D8	199.95	10.34	9.58	5.04	0.76	1.01	1.26	0.00	0.00
cerebrospinal fluid, donor2	10294-104G6	230.96	16.81	8.77	2.19	1.46	0.73	0.73	0.00	1.46
cervical cancer cell line:D98-AH2	10552-107I3	518.62	81.67	96.48	18.55	8.48	0.86	0.00	1.44	2.59
cervical cancer cell line:ME-180	10553-107I4	475.27	125.61	55.35	15.91	6.46	2.82	0.00	0.66	0.99
cervix, adult, pool1	10013-101C4	240.22	19.32	16.69	2.83	0.84	3.67	3.67	0.21	0.00
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	403.94	52.11	18.11	6.27	3.62	1.25	1.11	0.84	0.00
chondrosarcoma cell line:SW 1353	10700-109G7	175.04	13.06	23.51	3.92	0.00	0.00	1.31	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	393.21	38.53	19.14	11.93	7.08	0.87	0.37	0.99	0.50
choriocarcinoma cell line:SCH	10785-110H2	259.73	63.45	22.42	17.62	19.34	3.20	0.37	1.11	0.25
choriocarcinoma cell line:T3M-3	10618-108G6	239.79	35.10	9.96	10.20	9.25	0.47	0.24	0.00	0.71
chorionic membrane cells, donor1	12238-129G6	258.71	26.50	19.09	2.85	1.42	0.57	1.42	0.28	0.57
chorionic membrane cells, donor2	12239-129G7	423.97	49.12	30.92	7.66	7.95	0.99	0.80	0.50	0.80
chorionic membrane cells, donor3	12240-129G8	295.07	22.53	21.98	1.10	1.65	3.85	0.00	0.00	0.55
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	623.05	79.77	64.63	17.17	12.12	7.07	8.08	1.01	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	313.70	36.88	23.05	8.84	3.65	0.77	0.77	1.15	0.19
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	212.45	22.39	46.67	9.08	3.17	3.59	1.90	1.27	0.63
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	468.15	55.98	25.42	33.13	5.39	2.82	1.03	3.08	1.28
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	458.84	49.83	18.87	26.36	5.08	0.97	0.24	2.90	0.97
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	443.06	58.64	19.14	24.03	5.90	2.04	1.02	1.83	0.81
chronic myelogenous leukemia cell line:K562	10454-106G4	652.51	75.09	32.10	34.16	4.42	2.94	0.88	3.83	1.47
chronic myelogenous leukemia cell line:KU812	10409-106B4	467.04	87.31	56.03	33.10	5.73	4.17	4.95	2.87	0.78
clear cell carcinoma cell line:JHOC-5	10638-108I8	351.56	29.72	52.57	10.97	3.20	0.46	1.83	2.06	2.97
clear cell carcinoma cell line:TEN	10636-108I6	277.09	41.99	36.44	9.72	5.21	0.52	0.69	1.56	0.52
colon carcinoma cell line:CACO-2	10513-107D9	259.74	36.24	23.25	7.87	3.66	2.01	0.92	2.20	0.37
colon carcinoma cell line:COLO-320	10420-106C6	636.26	50.93	23.95	12.16	4.94	3.42	0.76	0.00	1.90
colon, adult, donor1	10082-102B1	267.76	23.80	29.75	5.95	1.19	3.57	2.38	0.00	1.19
colon, adult, pool1	10014-101C5	216.91	15.39	21.15	2.47	0.82	2.70	1.65	0.12	0.00
colon, fetal, donor1	10070-101I7	100.73	6.18	6.18	1.24	0.00	0.62	1.24	0.00	0.00
common myeloid progenitor CMP, donor1	12130-128D6	554.61	64.17	73.34	9.17	0.00	0.00	0.00	4.58	4.58
common myeloid progenitor CMP, donor2	12134-128E1	350.51	50.07	125.18	0.00	0.00	25.04	25.04	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	511.62	87.11	15.72	14.45	3.40	0.85	0.42	1.27	0.42
cord blood derived cell line:COBL-a 24h infection	10453-106G3	756.02	129.20	25.96	25.21	1.36	0.75	0.91	5.13	0.91
cord blood derived cell line:COBL-a untreated	10449-106F8	840.29	149.05	32.15	31.45	2.68	0.85	0.71	4.37	0.71
corpus callosum, adult, pool1	10042-101F6	227.32	18.57	5.42	4.86	1.11	6.74	12.16	0.00	0.22
cruciate ligament, donor2	10295-104G7	256.11	29.18	12.97	7.29	1.62	0.00	0.00	0.81	0.00
diaphragm, fetal, donor1	10069-101I6	210.27	8.83	9.63	0.80	0.00	2.41	4.01	0.00	0.00
diencephalon, adult	10193-103E4	182.15	11.76	6.48	3.60	0.72	3.60	5.28	0.00	0.24
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	885.38	87.48	48.45	28.24	13.55	14.24	10.56	8.27	1.84
ductal cell carcinoma cell line:KLM-1	10438-106E6	412.10	52.57	46.67	13.59	0.77	1.03	0.26	0.26	0.77
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	283.81	90.27	42.85	28.16	8.18	0.48	0.24	1.44	0.48
ductus deferens, adult	10196-103E7	204.32	7.48	8.47	2.49	0.50	0.00	0.50	0.00	0.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	151.22	5.76	12.96	0.00	1.44	2.88	0.00	0.00	1.44
duodenum, fetal, donor1, tech_rep2	10071-101I8	331.78	15.45	10.30	5.89	0.74	2.94	1.47	0.00	0.00
dura mater, adult, donor1	10041-101F5	421.19	45.67	42.62	6.94	3.30	2.56	4.05	0.33	0.00
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	610.48	177.21	18.43	41.31	12.21	17.77	2.22	9.99	1.33
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	895.01	129.97	14.33	58.89	7.88	5.45	3.58	2.44	0.29
embryonic pancreas cell line:1B2C6	10604-108F1	239.25	29.60	46.25	4.93	1.85	0.00	0.00	0.62	3.08
embryonic pancreas cell line:1C3D3	10605-108F2	295.45	39.05	35.72	7.57	3.33	0.30	0.30	1.51	3.03
embryonic pancreas cell line:1C3IKEI	10606-108F3	321.72	51.56	32.11	10.19	4.32	0.62	0.31	1.23	1.54
embryonic pancreas cell line:2C6	10603-108E9	291.59	30.21	36.78	5.25	6.57	0.00	1.31	1.31	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	279.22	32.51	23.46	5.70	1.68	1.34	0.34	2.01	0.34
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	468.86	44.95	33.17	9.24	2.36	2.36	2.72	0.91	1.99
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	490.32	58.05	48.73	12.70	5.15	1.93	0.80	1.13	1.29
epidermoid carcinoma cell line:A431	10426-106D3	309.47	67.36	49.80	15.67	5.89	1.11	0.33	0.78	1.45
epidermoid carcinoma cell line:Ca Ski	10431-106D8	573.57	106.80	103.06	29.59	12.98	2.42	0.44	1.87	3.08
epididymis, adult	10197-103E8	218.73	13.19	10.88	3.35	1.26	2.93	2.30	0.00	0.21
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	351.63	48.43	36.01	16.85	5.85	1.06	0.35	1.24	0.18
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	513.18	35.78	29.10	22.02	7.08	0.79	0.00	1.18	0.39
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	661.28	143.89	56.61	33.81	38.27	2.36	1.31	3.15	1.57
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	477.53	111.21	39.47	26.47	34.45	2.17	0.89	2.26	0.89
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	662.43	157.51	69.35	35.40	50.75	2.02	1.12	4.03	2.02
esophagus, adult, pool1	10015-101C6	281.16	43.32	40.03	8.92	4.03	2.76	1.70	0.21	0.74
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	337.89	44.71	12.52	7.26	1.13	0.88	0.50	0.63	0.25
eye - muscle inferior rectus, donor1	10272-104E2	239.04	7.24	4.83	0.00	0.00	2.41	0.00	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	294.59	18.94	0.00	4.21	0.00	2.10	0.00	0.00	0.00
eye - muscle medial, donor2	10299-104H2	151.80	11.91	7.44	1.49	0.00	1.49	1.49	0.00	0.00
eye - muscle superior, donor2	10297-104G9	225.86	30.96	3.44	3.44	0.00	1.15	0.00	0.00	0.00
eye - vitreous humor, donor1	10268-104D7	220.07	24.78	14.57	7.29	1.46	0.00	1.46	0.00	1.46
eye, fetal, donor1	10054-101G9	228.05	10.93	6.36	1.78	0.51	4.58	3.05	0.00	0.25
fibrosarcoma cell line:HT-1080	10758-110E2	418.27	61.55	33.21	16.80	9.23	0.77	1.54	2.31	1.67
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	415.25	116.34	67.90	35.85	21.13	1.19	0.24	2.37	3.56
frontal lobe, adult, pool1	10040-101F4	230.24	14.54	9.95	4.13	0.75	1.97	4.32	0.00	0.38
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	473.19	60.05	33.93	17.41	8.11	2.40	1.20	1.20	0.90
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	363.09	30.45	61.26	7.50	1.19	0.46	0.46	0.64	2.47
gall bladder, adult	10198-103E9	228.64	21.73	14.73	5.55	0.97	2.17	3.62	0.00	0.72
gamma delta positive T cells, donor1	11937-126A2	457.40	26.84	27.38	3.22	0.54	3.22	1.07	0.00	0.00
gamma delta positive T cells, donor2	11938-126A3	385.07	20.92	12.70	4.11	0.37	5.23	4.11	0.00	0.37
gastric adenocarcinoma cell line:MKN1	10614-108G2	340.69	60.20	32.53	10.77	4.65	1.06	1.06	0.42	0.21
gastric adenocarcinoma cell line:MKN45	10612-108F9	441.76	55.32	61.31	10.64	5.22	2.32	0.19	0.77	1.16
gastric cancer cell line:AZ521	10549-107H9	570.40	124.77	33.12	39.02	10.98	0.66	3.28	2.30	2.46
gastric cancer cell line:GSS	10560-108A2	281.89	24.71	39.35	16.47	0.92	2.75	2.75	0.00	3.66
gastrointestinal carcinoma cell line:ECC12	10615-108G3	209.04	16.22	5.94	2.74	0.69	2.51	0.91	0.46	0.23
giant cell carcinoma cell line:LU65	10487-107B1	526.54	154.21	81.47	43.37	11.59	2.52	0.23	2.75	1.95
giant cell carcinoma cell line:Lu99B	10433-106E1	165.01	35.69	14.70	16.66	4.06	0.00	0.28	0.00	0.00
glassy cell carcinoma cell line:HOKUG	10688-109F4	310.28	50.13	29.18	7.48	2.24	0.75	0.00	0.25	1.25
glioblastoma cell line:A172, tech_rep1	10444-106F3	358.77	41.27	26.18	7.71	1.79	1.06	1.48	0.32	1.79
glioblastoma cell line:A172, tech_rep2	10444-106F3	327.08	37.36	24.30	7.30	2.25	0.56	1.40	0.56	0.70
glioblastoma cell line:T98G	10485-107A8	554.85	42.82	33.44	8.94	3.53	1.32	0.88	1.55	1.32
glioma cell line:GI-1	10413-106B8	257.73	23.14	14.35	4.10	2.05	0.00	0.88	0.00	0.59
globus pallidus - adult, donor10196	10175-103C4	118.81	5.10	2.19	0.73	0.73	2.19	3.64	0.00	0.00
globus pallidus, adult, donor10252	10161-103A8	167.94	13.67	10.74	2.44	0.98	5.61	10.50	0.24	0.49
globus pallidus, adult, donor10258	10367-105F7	238.24	2.74	2.74	1.37	0.00	6.85	10.95	0.00	0.00
globus pallidus, newborn, donor10223	10364-105F4	222.23	12.79	11.19	3.20	0.00	2.13	2.66	0.00	0.53
granulocyte macrophage progenitor, donor1	12131-128D7	675.41	127.25	107.67	34.26	9.79	0.00	2.45	2.45	2.45
granulocyte macrophage progenitor, donor2	12135-128E2	437.14	21.86	109.28	32.79	0.00	0.00	76.50	10.93	10.93
granulocyte macrophage progenitor, donor3	12139-128E6	763.08	57.49	151.57	15.68	20.91	31.36	26.13	5.23	0.00
granulosa cell tumor cell line:KGN	10624-108H3	301.76	22.40	38.72	2.56	0.96	0.96	1.28	0.64	0.64
hIPS +CCl2, biol_rep1	14383-156B9	516.96	61.98	44.99	24.33	9.64	3.21	0.92	21.12	2.30
hIPS +CCl2, biol_rep2	14384-156C1	572.04	80.02	36.58	47.56	6.40	1.83	1.83	18.75	1.83
hIPS +CCl2, biol_rep3	14385-156C2	604.16	81.16	43.15	40.58	9.66	5.15	3.86	24.48	3.86
hIPS, biol_rep1	14380-156B6	965.86	112.11	40.24	90.55	2.87	11.50	4.31	30.18	2.87
hIPS, biol_rep2	14381-156B7	740.74	106.31	37.04	45.95	8.23	4.80	2.74	19.20	2.74
hIPS, biol_rep3	14382-156B8	239.45	20.97	15.45	6.62	1.10	2.21	7.72	5.52	1.10
hairy cell leukemia cell line:Mo	10712-109I1	417.22	97.98	37.35	24.42	5.17	2.30	2.01	1.72	1.72
heart - mitral valve, adult	10205-103F7	182.67	9.87	4.78	1.49	0.90	3.29	1.79	0.00	0.00
heart - pulmonic valve, adult	10206-103F8	194.54	7.32	1.83	2.35	0.78	2.09	2.09	0.00	0.00
heart - tricuspid valve, adult	10207-103F9	285.60	40.80	32.47	6.66	0.00	1.67	0.00	0.00	0.83
heart, adult, diseased post-infarction, donor1	10050-101G5	317.10	29.79	40.40	4.90	3.88	1.84	0.82	0.41	1.02
heart, adult, diseased, donor1	10051-101G6	356.85	8.52	4.26	2.55	0.00	2.13	4.26	0.00	0.00
heart, adult, pool1	10016-101C7	249.76	17.25	9.20	2.07	0.69	2.30	2.07	0.23	0.00
heart, fetal, pool1	10046-101G1	314.10	12.01	6.37	1.44	0.51	5.03	5.75	0.00	0.72
hepatic mesenchymal tumor cell line:LI90	10778-110G4	224.91	17.89	37.95	1.85	0.93	0.00	0.31	0.00	1.23
hepatoblastoma cell line:HuH-6	10633-108I3	243.78	20.22	8.32	2.38	2.38	0.00	0.00	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	506.40	65.52	43.87	11.82	19.78	2.76	1.88	4.42	0.77
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	556.38	81.56	54.62	12.02	22.09	4.37	2.55	7.77	1.21
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	528.21	68.82	47.90	14.65	17.08	3.13	2.53	6.77	1.01
hepatoma cell line:Li-7	10484-107A7	296.06	37.81	17.35	5.67	2.00	2.56	0.56	0.44	0.22
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	922.49	158.99	40.90	43.62	41.51	3.72	4.32	8.24	1.51
hippocampus - adult, donor10196	10169-103B7	137.22	5.68	10.41	3.79	0.95	0.95	2.84	0.00	0.00
hippocampus, adult, donor10252	10153-102I9	128.38	8.16	6.94	1.22	1.02	3.06	5.71	0.00	0.00
hippocampus, adult, donor10258	10374-105G5	268.89	14.94	4.98	4.48	0.00	1.00	2.99	0.50	1.49
hippocampus, newborn, donor10223	10363-105F3	197.74	12.69	8.81	7.05	0.00	1.06	0.70	0.35	1.06
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	838.61	121.46	52.49	50.66	12.82	9.16	1.22	31.74	3.05
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	561.57	74.61	55.37	30.83	18.06	3.14	1.18	14.73	1.96
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	566.95	77.69	46.72	43.67	7.62	4.82	1.02	18.79	2.54
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	252.05	11.28	12.97	5.07	0.00	2.26	1.13	2.82	1.69
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	253.05	11.88	11.10	3.36	2.32	3.10	2.32	1.29	1.03
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	412.26	14.80	18.60	9.87	1.14	3.80	3.04	3.04	0.76
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	267.43	9.93	8.17	2.34	0.29	2.34	3.80	0.88	0.29
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	266.05	10.13	11.20	3.23	0.86	1.72	2.80	1.29	0.43
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	293.20	10.01	11.68	3.75	0.00	2.50	2.50	2.09	0.83
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	554.81	23.21	14.44	6.87	1.66	5.21	3.55	2.37	1.18
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	381.06	18.16	12.54	4.18	1.77	3.38	3.70	2.25	0.32
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	527.87	29.63	12.79	7.41	2.02	4.04	4.04	2.69	0.67
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	513.58	74.02	52.27	34.27	18.15	4.85	1.72	18.62	2.35
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	655.39	97.28	58.96	40.29	19.65	6.39	0.49	24.56	4.42
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	639.73	54.11	41.89	47.13	6.98	2.62	2.62	16.58	2.62
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	267.66	9.74	11.45	3.63	2.10	4.01	1.91	1.15	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	291.30	10.47	13.52	4.80	3.92	2.62	3.05	0.44	0.87
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	248.38	13.99	12.49	3.50	0.50	1.50	2.00	1.00	1.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	155.05	6.59	6.59	1.51	0.75	0.38	2.64	0.38	0.38
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	191.89	6.37	4.09	1.82	0.91	0.00	0.45	0.00	0.91
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	161.32	7.52	8.14	0.63	0.00	0.00	0.94	0.31	0.63
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	279.25	11.59	7.02	2.61	0.33	1.31	2.12	0.65	0.49
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	317.60	12.48	12.77	2.61	0.87	2.32	2.90	1.74	0.29
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	251.69	7.47	9.86	2.69	0.90	0.90	2.09	0.60	1.20
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	563.66	86.65	48.22	29.56	18.84	3.51	2.03	15.33	2.96
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	582.84	91.58	53.06	29.10	14.26	5.71	1.43	15.12	0.86
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	781.51	116.78	57.16	46.14	10.62	7.35	3.67	21.23	4.49
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	352.78	30.28	12.67	7.75	5.28	5.28	2.82	2.82	0.70
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	306.92	18.05	12.35	5.70	3.17	1.58	2.53	2.22	0.32
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	355.28	21.79	12.71	9.68	0.61	5.45	1.21	3.03	1.21
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	254.42	10.86	10.34	5.17	0.00	0.52	3.10	2.07	0.52
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	236.44	6.64	9.96	2.66	0.66	0.66	1.33	1.33	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	286.29	11.54	7.70	4.36	0.00	2.57	2.31	1.28	0.51
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	422.33	22.75	17.64	3.83	1.02	2.30	3.58	1.28	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	395.27	20.45	9.09	2.27	0.76	0.00	3.79	0.76	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	355.88	19.83	12.10	5.04	0.34	1.68	2.35	2.02	0.67
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	588.31	94.19	61.34	29.22	25.60	4.83	1.45	15.70	3.86
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	594.95	75.32	47.24	38.77	4.90	7.13	2.67	17.83	1.78
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	551.71	83.90	56.10	27.32	7.32	5.37	1.95	21.95	3.90
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	317.23	17.42	11.61	4.89	2.44	4.28	2.75	2.14	0.61
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	595.34	19.52	9.76	3.25	9.76	9.76	13.01	3.25	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	366.02	15.55	8.94	5.96	0.99	4.63	2.98	2.65	0.66
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	372.71	12.04	6.02	2.74	1.09	2.19	3.28	0.55	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	262.37	9.41	4.70	1.09	0.36	3.26	1.09	0.72	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	246.26	9.96	5.34	3.56	0.36	2.49	2.85	0.00	0.71
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	390.24	14.32	8.35	9.55	0.00	3.58	0.00	4.77	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	483.06	25.05	14.90	6.36	1.63	4.06	4.47	2.30	0.68
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	306.57	11.31	9.70	3.50	0.81	3.23	1.35	1.89	0.27
immature langerhans cells, donor1	11904-125F5	402.69	37.29	44.07	8.96	2.18	5.57	5.33	0.24	0.48
immature langerhans cells, donor2	11905-125F6	349.33	53.07	34.06	11.09	0.79	3.17	5.54	1.58	1.58
insula, adult, pool1	10039-101F3	254.56	15.99	11.55	5.96	1.89	1.51	5.58	0.00	0.76
keratoacanthoma cell line:HKA-1	10791-110H8	440.58	55.60	100.80	13.33	6.83	0.98	0.33	1.63	1.95
kidney, adult, pool1	10017-101C8	270.34	20.03	13.12	4.41	1.50	2.20	2.50	0.00	0.20
kidney, fetal, pool1	10045-101F9	270.14	16.84	5.31	3.04	1.27	3.47	4.39	0.00	0.28
large cell lung carcinoma cell line:IA-LM	10509-107D5	333.61	41.33	41.75	9.52	2.41	1.70	1.70	1.56	1.42
large cell lung carcinoma cell line:NCI-H460	10839-111E2	471.27	40.50	29.86	6.50	2.49	0.28	0.28	0.83	1.38
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	200.38	36.33	36.33	6.06	5.14	1.83	0.55	0.18	1.65
left atrium, adult, donor1	10079-102A7	131.85	3.27	7.63	1.09	0.00	1.63	0.54	0.00	0.54
left ventricle, adult, donor1	10078-102A6	166.87	3.54	8.09	1.01	0.00	1.01	0.51	0.00	0.00
leiomyoblastoma cell line:G-402	10721-110A1	514.39	62.66	36.94	18.33	7.66	0.27	0.00	2.19	0.82
leiomyoma cell line:10964C	10569-108B2	473.13	68.62	82.99	21.20	6.11	0.36	0.36	1.08	0.72
leiomyoma cell line:15242A	10570-108B3	413.05	61.96	69.02	18.48	3.80	0.00	0.00	1.63	2.17
leiomyoma cell line:15425	10571-108B4	470.09	67.26	71.87	21.61	3.40	0.49	0.24	0.24	0.49
leiomyosarcoma cell line:Hs 5.T	10722-110A2	463.50	12.70	76.19	6.35	0.00	0.00	0.00	0.00	6.35
lens epithelial cell line:SRA 01/04	10647-109A8	237.34	18.82	2.09	0.00	2.09	0.00	0.00	0.00	2.09
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	501.39	75.20	44.74	25.97	5.78	4.72	1.77	4.37	0.83
liposarcoma cell line:KMLS-1	10782-110G8	348.50	39.36	24.68	10.31	2.97	0.94	0.78	0.47	0.78
liposarcoma cell line:SW 872	10726-110A6	413.16	20.96	45.45	4.51	3.17	2.56	5.85	0.61	1.34
liver, adult, pool1	10018-101C9	623.77	111.82	23.01	13.13	7.94	3.89	1.94	0.32	1.13
liver, fetal, pool1	10086-102B5	193.79	23.52	14.11	5.64	0.94	0.94	0.94	0.00	0.00
locus coeruleus - adult, donor10196	10182-103D2	84.87	5.25	6.42	1.60	0.44	1.02	3.35	0.15	0.29
locus coeruleus, adult, donor10252	10165-103B3	151.52	9.78	8.67	1.11	0.92	2.40	4.98	0.00	0.00
locus coeruleus, adult, donor10258	10375-105G6	108.06	7.34	9.59	1.41	0.56	1.69	3.67	0.00	0.00
locus coeruleus, newborn, donor10223	10362-105F2	172.87	15.14	7.15	2.94	0.00	2.52	3.36	0.00	0.42
lung adenocarcinoma cell line:A549	10499-107C4	318.58	43.59	21.17	11.49	5.54	1.11	0.69	0.97	0.97
lung adenocarcinoma cell line:PC-14	10408-106B3	355.04	32.40	35.16	6.20	1.38	0.69	0.00	1.38	0.69
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	392.94	26.76	86.74	8.57	3.69	0.26	1.05	1.45	3.16
lung, adult, pool1	10019-101D1	224.32	23.39	17.36	3.90	2.24	3.31	2.72	0.12	0.47
lung, fetal, donor1	10068-101I5	266.57	16.55	4.85	3.14	0.00	1.43	2.57	0.29	0.00
lung, right lower lobe, adult, donor1	10075-102A3	122.80	11.46	9.62	2.29	0.00	0.00	1.83	0.00	0.00
lymph node, adult, donor1	10077-102A5	222.48	14.20	28.40	2.37	2.84	1.89	2.84	0.95	0.95
lymphangiectasia cell line:DS-1	10727-110A7	502.14	64.22	44.05	14.25	11.62	8.77	3.51	3.51	1.32
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	421.84	49.96	37.43	9.66	5.58	11.32	6.64	6.94	0.60
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	452.78	101.94	52.67	29.73	5.95	0.00	0.00	0.00	0.85
mature adipocyte, donor1	12231-129F8	297.92	24.86	23.98	4.44	1.78	2.66	0.89	0.44	0.89
mature adipocyte, donor2	12232-129F9	257.75	21.17	26.56	3.94	1.25	1.25	1.66	0.21	0.21
mature adipocyte, donor3	12233-129G1	272.39	30.58	26.08	4.50	2.37	1.90	1.90	0.24	0.71
mature adipocyte, donor4	12234-129G2	269.53	20.79	22.90	2.11	1.32	3.42	2.90	0.53	0.79
maxillary sinus tumor cell line:HSQ-89	10414-106B9	296.16	35.98	39.31	11.44	2.38	3.57	1.43	0.48	1.43
medial frontal gyrus - adult, donor10196	10170-103B8	136.49	7.90	5.64	3.38	1.13	3.38	2.26	0.00	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	130.94	5.33	4.78	1.29	0.55	2.21	4.41	0.00	0.00
medial frontal gyrus, adult, donor10258	10368-105F8	133.75	7.94	6.04	2.22	0.64	1.59	2.86	0.00	0.95
medial frontal gyrus, newborn, donor10223	10352-105E1	276.79	9.38	4.69	7.25	0.43	1.28	1.71	0.85	0.00
medial temporal gyrus - adult, donor10196	10183-103D3	105.64	7.76	6.41	3.71	0.84	1.69	2.53	0.00	0.00
medial temporal gyrus, adult, donor10252	10156-103A3	139.22	6.37	3.40	1.27	1.27	2.97	5.52	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	325.54	5.78	11.56	19.26	0.00	0.00	1.93	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	287.07	57.41	0.00	28.71	0.00	14.35	14.35	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	212.49	10.41	6.46	3.95	0.00	0.36	0.36	0.00	0.00
medulla oblongata - adult, donor10196	10174-103C3	126.55	5.19	1.95	1.95	0.65	6.49	2.60	0.00	0.00
medulla oblongata, adult, donor10252	10155-103A2	135.76	9.29	6.50	1.86	0.62	3.72	5.73	0.00	0.15
medulla oblongata, adult, pool1	10038-101F2	198.27	16.08	9.31	3.92	1.39	2.86	7.59	0.08	0.33
medulla oblongata, newborn, donor10223	10361-105F1	194.42	12.15	7.29	2.43	0.00	2.08	1.04	0.00	0.00
medulloblastoma cell line:D283 Med	10838-111E1	268.13	29.23	13.95	11.07	3.10	5.09	1.77	0.44	0.66
medulloblastoma cell line:ONS-76	10759-110E3	247.24	36.68	24.09	7.95	4.77	0.49	0.12	0.61	0.73
melanoma cell line:COLO 679	10514-107E1	526.40	103.35	34.79	18.11	5.03	1.87	0.57	3.02	1.29
melanoma cell line:G-361	10465-106H6	287.21	45.61	19.82	11.94	2.44	0.00	0.27	0.54	0.27
meningioma cell line:HKBMM	10691-109F7	331.24	38.53	37.63	6.51	1.99	0.90	0.90	1.63	1.45
merkel cell carcinoma cell line:MKL-1	10843-111E6	548.96	36.13	26.43	9.69	1.76	1.76	1.76	0.00	2.64
merkel cell carcinoma cell line:MS-1	10844-111E7	512.74	29.55	23.33	6.74	1.81	2.59	3.37	0.00	1.04
mesenchymal precursor cell - adipose, donor1	11747-123G1	883.63	184.12	76.72	41.73	24.24	0.92	0.92	2.15	1.53
mesenchymal precursor cell - adipose, donor2	11748-123G2	495.17	83.62	47.44	14.18	7.27	0.91	0.36	0.91	0.73
mesenchymal precursor cell - adipose, donor3	11749-123G3	698.18	177.24	69.98	47.62	11.59	0.41	0.41	2.07	0.83
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	358.21	31.75	59.42	5.34	1.12	0.42	0.70	0.28	1.55
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	347.20	42.17	62.58	8.28	2.31	0.77	0.19	0.77	0.77
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	310.95	34.70	36.09	13.19	0.00	1.39	0.69	0.69	1.39
mesenchymal precursor cell - cardiac, donor1	11752-123G6	389.61	53.72	95.94	6.87	5.49	0.69	1.37	1.54	2.23
mesenchymal precursor cell - cardiac, donor2	11753-123G7	433.38	70.62	71.88	11.96	6.33	0.58	0.69	0.69	1.61
mesenchymal precursor cell - cardiac, donor3	11754-123G8	670.88	120.83	66.58	19.50	13.53	0.80	0.80	1.33	1.86
mesenchymal precursor cell - cardiac, donor4	11755-123G9	619.56	124.37	76.84	25.12	7.43	0.27	0.68	2.16	1.35
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	510.87	89.34	41.26	15.22	11.38	1.14	1.00	1.56	0.43
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	264.80	33.26	39.52	9.22	0.99	0.99	0.00	0.66	0.33
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	563.45	89.80	46.63	17.71	9.27	0.55	0.83	1.52	1.38
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	483.48	71.21	65.98	18.85	1.75	0.35	0.00	0.35	2.09
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	491.83	71.87	61.66	13.47	8.17	1.02	1.02	0.00	0.82
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	271.75	33.79	34.51	10.06	1.08	0.00	0.00	0.72	1.44
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	368.38	33.10	36.72	6.00	2.48	0.52	0.41	0.31	0.72
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	290.23	57.00	41.49	10.94	2.51	0.46	0.00	0.91	0.68
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	524.03	125.87	62.09	23.91	13.43	0.42	0.84	2.94	1.26
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	471.33	64.86	41.10	8.37	6.28	0.75	1.49	1.20	1.34
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	461.90	56.02	48.84	9.10	7.62	0.70	0.18	0.96	1.23
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	343.86	31.29	36.08	7.00	0.74	0.37	0.37	0.00	1.47
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	329.65	44.93	44.07	12.30	2.00	0.57	0.00	0.29	0.57
mesenchymal stem cell line:Hu5/E18	10568-108B1	551.11	59.78	59.36	18.95	6.32	0.84	1.26	0.84	1.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	489.09	58.45	50.23	16.90	5.02	0.00	0.46	0.46	0.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	437.65	58.06	42.97	16.11	5.63	2.05	1.79	1.02	0.77
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	485.56	59.94	51.57	15.44	3.66	1.05	0.26	0.00	0.52
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	483.08	57.30	43.13	17.56	3.39	1.54	1.85	0.00	1.85
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	458.47	56.49	45.19	18.12	4.24	0.94	1.41	0.71	0.71
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	481.28	62.95	48.06	18.62	4.06	0.68	0.34	0.34	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	516.76	55.41	43.23	16.90	5.89	0.39	0.39	0.79	0.79
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	453.65	60.70	38.46	14.83	3.71	1.39	0.93	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	483.04	0.00	0.00	48.30	48.30	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	537.32	68.93	58.26	22.50	5.19	0.58	2.02	0.00	0.29
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	486.58	58.45	54.44	20.30	5.80	1.12	2.23	0.45	1.34
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	481.18	53.12	50.47	15.38	3.61	0.96	0.72	0.24	1.20
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	442.20	56.47	35.93	13.20	7.33	0.00	0.00	0.00	0.73
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	431.65	56.05	37.93	14.77	2.35	1.68	0.67	0.67	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	435.99	43.80	38.48	15.56	4.09	0.82	1.23	0.00	0.82
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	449.32	57.99	50.69	15.46	3.87	0.86	1.72	0.00	0.86
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	508.60	46.48	49.22	19.14	0.00	0.00	5.47	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	439.02	82.64	36.15	36.15	0.00	0.00	0.00	5.16	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	489.45	47.42	46.12	15.26	1.62	0.65	1.30	0.32	1.30
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	504.88	61.11	43.65	16.00	0.00	0.00	0.00	0.00	1.45
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	526.15	55.97	43.18	19.19	3.20	2.13	1.60	1.07	1.07
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	478.40	46.61	41.71	13.08	2.45	0.82	0.82	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	454.41	46.26	41.20	16.33	0.78	0.78	0.39	0.00	1.55
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	394.56	27.28	31.48	23.09	0.00	2.10	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	442.09	45.70	45.70	17.88	0.99	2.98	0.00	0.99	0.99
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	486.26	57.21	42.90	23.84	0.00	4.77	4.77	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	431.68	50.40	52.77	15.42	0.00	2.37	2.37	0.00	1.19
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	600.70	56.05	40.21	13.40	2.44	2.44	0.00	1.22	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	324.63	27.05	27.05	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	514.94	52.57	57.64	17.73	0.63	0.00	0.63	0.63	1.27
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	323.52	27.25	41.04	8.62	0.34	0.69	0.69	0.34	1.03
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	354.62	23.64	49.43	8.60	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	407.16	55.89	55.89	11.98	0.00	0.00	3.99	0.00	3.99
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	272.07	27.55	37.88	0.00	0.00	3.44	3.44	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	291.75	26.49	46.45	8.15	1.63	0.81	2.04	0.41	1.22
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	286.79	28.60	42.90	7.15	3.97	5.56	1.59	0.00	0.79
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	298.89	27.71	42.45	4.13	1.77	2.95	1.77	1.18	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	253.42	22.13	31.79	5.30	1.25	1.56	0.31	0.62	0.31
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	302.09	32.08	37.43	6.68	1.34	2.67	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	438.77	75.69	41.39	20.11	0.00	3.55	2.37	0.00	1.18
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	395.47	102.72	35.95	20.54	10.27	0.00	2.57	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	468.80	112.90	45.43	17.90	4.13	2.75	3.44	0.00	2.07
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	545.28	82.14	68.28	14.84	4.95	0.99	0.99	0.00	0.49
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	512.53	69.53	61.68	20.19	3.36	1.12	0.00	0.00	1.12
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	559.10	81.42	53.43	19.08	7.00	0.64	0.64	0.00	0.64
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	514.21	70.93	60.04	10.48	4.03	0.40	0.40	0.40	0.40
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	484.09	100.31	47.97	19.63	0.00	0.00	2.18	0.00	4.36
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	533.43	82.36	41.81	13.94	2.53	0.00	0.00	0.00	1.27
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	260.35	33.99	28.52	6.07	3.64	0.61	0.00	0.00	1.21
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	289.21	58.75	27.11	13.56	4.52	9.04	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	270.99	37.07	25.53	5.77	3.29	1.65	0.82	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	293.87	31.55	35.92	6.15	0.79	0.99	0.40	0.00	0.20
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	290.75	32.12	41.54	6.49	2.27	0.65	1.95	0.32	1.30
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	323.92	38.71	44.82	11.20	2.04	0.00	1.02	0.00	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	162.48	11.61	20.12	3.09	0.77	0.77	0.77	0.00	0.77
mesothelioma cell line:ACC-MESO-1	10493-107B7	520.68	64.26	44.89	16.77	7.80	0.71	0.24	0.24	2.13
mesothelioma cell line:ACC-MESO-4	10494-107B8	347.97	46.10	44.48	7.88	1.62	1.39	1.62	1.62	1.85
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	931.64	119.66	55.56	21.37	8.55	0.00	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	464.12	84.05	57.44	18.08	6.17	1.13	1.03	2.06	0.31
mesothelioma cell line:Mero-25	10850-111F4	522.67	119.83	29.05	24.28	7.26	3.86	0.68	2.72	0.68
mesothelioma cell line:Mero-41	10851-111F5	588.45	40.09	54.27	13.94	1.47	0.98	0.24	1.71	0.49
mesothelioma cell line:Mero-48a	10852-111F6	887.05	81.04	79.72	21.70	2.44	4.21	1.11	2.66	2.88
mesothelioma cell line:Mero-82	10853-111F7	675.67	118.00	64.65	27.33	8.94	3.15	1.58	2.89	1.05
mesothelioma cell line:Mero-83	10854-111F8	463.17	63.66	44.94	18.72	2.72	0.68	0.68	0.85	1.19
mesothelioma cell line:Mero-84	10855-111F9	734.31	55.61	45.75	17.44	1.01	2.02	1.52	2.02	1.26
mesothelioma cell line:Mero-95	10856-111G1	537.69	60.87	71.64	20.70	3.93	0.62	0.41	2.07	2.28
mesothelioma cell line:NCI-H2052	10847-111F1	685.62	102.54	72.55	27.66	7.62	1.49	0.83	1.99	1.99
mesothelioma cell line:NCI-H226	10846-111E9	692.11	122.17	57.37	26.42	4.89	1.99	1.09	5.07	0.90
mesothelioma cell line:NCI-H2452	10848-111F2	928.93	88.83	77.55	25.79	3.42	1.71	2.22	2.22	3.25
mesothelioma cell line:NCI-H28	10845-111E8	391.11	35.63	20.87	8.91	0.76	1.27	0.51	0.00	0.25
mesothelioma cell line:No36	10857-111G2	689.59	96.88	36.21	33.27	7.50	1.63	1.63	1.30	0.98
mesothelioma cell line:ONE58	10858-111G3	327.31	20.86	22.76	10.30	0.81	1.08	0.00	1.08	0.27
migratory langerhans cells, donor1	11901-125F2	357.17	13.82	8.25	2.69	0.38	13.82	4.99	0.38	0.19
migratory langerhans cells, donor2	11902-125F3	412.02	13.07	9.77	2.69	0.49	10.38	2.81	0.24	0.24
migratory langerhans cells, donor3	11903-125F4	360.58	13.10	18.49	3.95	0.36	7.72	5.92	0.18	0.18
mixed mullerian tumor cell line:HTMMT	10689-109F5	350.31	31.02	38.52	5.22	2.94	0.65	0.65	0.33	0.33
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	358.81	61.67	66.97	13.56	7.21	3.18	2.12	1.91	2.97
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	383.08	62.66	94.22	13.13	8.98	0.23	0.00	0.46	3.46
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	449.66	68.12	33.11	6.66	4.00	1.14	1.33	0.76	0.76
myelodysplastic syndrome cell line:SKM-1	10772-110F7	468.45	64.68	40.65	14.41	12.75	3.88	2.22	1.66	0.37
myeloma cell line:PCM6	10474-106I6	168.81	10.08	46.45	1.98	0.40	2.97	0.99	1.98	0.59
myxofibrosarcoma cell line:MFH-ino	10600-108E6	415.98	33.48	125.81	8.62	1.01	1.52	1.01	0.00	3.04
myxofibrosarcoma cell line:NMFH-1	10684-109E9	290.48	34.72	52.96	5.88	3.33	1.37	0.39	0.59	0.78
nasal epithelial cells, donor1, tech_rep1	12226-129F3	283.35	54.15	108.19	14.26	10.03	0.33	0.00	0.56	2.90
nasal epithelial cells, donor1, tech_rep2	12226-129F3	231.28	48.24	93.84	17.28	5.59	0.44	0.07	0.44	1.84
nasal epithelial cells, donor2	12227-129F4	569.65	141.31	80.04	27.60	7.73	1.66	1.10	1.10	1.10
neuroblastoma cell line:CHP-134	10508-107D4	444.25	19.10	16.33	3.22	0.69	6.21	4.37	0.46	0.92
neuroblastoma cell line:NB-1	10539-107G8	698.95	64.92	41.53	16.09	4.86	1.87	4.68	1.31	2.06
neuroblastoma cell line:NBsusSR	10607-108F4	522.58	22.78	18.35	4.22	3.37	5.48	4.22	0.00	1.69
neuroblastoma cell line:NH-12	10555-107I6	350.71	22.73	10.62	3.73	1.68	2.61	2.61	0.37	0.19
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	171.28	6.64	6.41	0.47	0.24	1.42	3.80	0.00	0.24
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	327.85	34.84	26.13	5.23	2.53	1.58	2.22	0.16	0.79
neuroectodermal tumor cell line:TASK1	10774-110F9	625.72	54.94	42.26	10.67	5.43	1.21	3.02	1.81	1.21
neuroepithelioma cell line:SK-N-MC	10728-110A8	195.82	8.26	15.26	4.45	0.00	0.00	0.00	0.00	0.64
neurofibroma cell line:Hs 53.T	10729-110A9	392.86	35.93	59.09	6.39	1.06	1.60	0.27	0.27	0.80
neutrophil PMN, donor1	12133-128D9	178.50	0.00	14.87	0.00	0.00	14.87	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	159.37	13.28	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	227.30	0.00	9.47	0.00	0.00	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	340.61	26.38	18.10	7.10	5.58	3.04	6.43	0.51	0.34
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	1075.88	68.84	104.07	20.81	3.20	4.80	3.20	2.40	0.80
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	307.46	30.14	34.63	6.41	2.24	0.32	0.64	0.64	0.32
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	323.20	27.33	33.90	4.99	1.31	0.79	0.79	0.00	1.05
nucleus accumbens, adult, pool1	10037-101F1	228.07	11.90	10.41	6.00	1.31	2.25	5.81	0.00	0.00
occipital cortex - adult, donor10196	10172-103C1	111.26	12.36	2.06	8.24	0.00	0.00	0.00	0.00	0.00
occipital cortex, adult, donor10252	10163-103B1	133.11	9.39	4.29	1.88	0.81	3.76	5.64	0.00	0.00
occipital cortex, newborn, donor10223	10355-105E4	268.95	11.28	7.64	8.37	0.00	0.36	0.36	0.00	0.36
occipital lobe, adult, donor1	10076-102A4	158.23	8.92	9.71	2.89	2.10	1.57	3.67	0.00	0.26
occipital lobe, fetal, donor1	10073-102A1	200.82	4.29	6.87	1.29	0.00	1.72	3.00	0.00	0.00
occipital pole, adult, pool1	10036-101E9	248.90	15.14	8.36	4.89	1.42	2.84	5.91	0.00	0.47
olfactory region, adult	10195-103E6	167.55	9.93	6.69	2.87	1.15	2.67	4.01	0.00	0.19
optic nerve, donor1	10277-104E7	238.12	10.01	4.00	0.00	0.00	2.00	0.00	0.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	375.78	56.50	40.67	11.50	4.44	1.59	0.80	2.16	1.03
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	488.55	54.41	102.49	14.70	4.67	0.14	0.96	2.47	2.75
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	354.90	57.06	57.40	14.22	3.22	0.85	0.51	0.68	1.52
oral squamous cell carcinoma cell line:SAS	10544-107H4	569.46	141.61	92.06	31.88	17.44	0.81	0.58	1.85	3.47
osteoclastoma cell line:Hs 706.T	10704-109H2	340.41	32.34	33.51	7.06	1.18	1.47	0.59	0.29	1.18
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	402.70	42.05	32.70	15.88	2.80	0.93	0.93	0.00	1.87
osteosarcoma cell line:HS-Os-1	10558-107I9	381.28	42.62	16.12	7.21	2.33	2.76	0.85	1.27	0.42
ovary, adult, pool1	10020-101D2	221.26	18.43	5.07	1.66	0.96	3.41	4.19	0.09	0.09
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	236.30	26.95	28.05	6.60	3.30	0.55	0.92	0.92	0.55
pancreas, adult, donor1	10049-101G4	496.66	45.15	45.15	3.76	5.64	1.88	0.94	1.88	1.88
pancreatic carcinoma cell line:NOR-P1	10698-109G5	205.46	26.84	15.37	6.15	3.91	1.68	0.00	0.84	0.84
papillary adenocarcinoma cell line:8505C	10437-106E5	474.09	72.23	39.35	15.16	5.45	2.73	0.34	1.19	1.02
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	148.36	22.19	22.19	1.99	1.32	0.33	0.50	0.17	1.16
paracentral gyrus, adult, pool1	10035-101E8	220.29	14.46	9.79	5.22	1.28	1.92	5.67	0.00	0.46
parietal cortex, adult, donor10258	10373-105G4	399.30	24.22	9.54	7.34	1.47	2.94	4.40	0.00	2.20
parietal lobe - adult, donor10196	10171-103B9	126.02	10.35	6.58	0.00	0.00	0.94	1.88	0.00	0.00
parietal lobe, adult, donor10252	10157-103A4	129.98	5.42	3.71	1.71	0.57	2.57	3.99	0.00	0.00
parietal lobe, adult, pool1	10034-101E7	199.33	13.31	8.46	4.67	1.23	2.20	7.23	0.00	0.26
parietal lobe, fetal, donor1	10072-101I9	221.12	0.97	3.88	0.00	0.00	2.91	2.91	0.00	0.00
parietal lobe, newborn, donor10223	10356-105E5	224.69	10.47	12.34	4.11	0.00	0.37	0.37	0.00	0.75
parotid gland, adult	10199-103F1	378.63	12.95	43.78	3.08	0.62	2.47	0.62	0.62	1.85
penis, adult	10200-103F2	217.53	13.43	6.98	2.69	0.54	1.61	2.15	0.00	0.54
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	236.51	25.29	8.74	2.05	0.19	1.86	1.67	0.00	0.19
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	365.11	57.26	97.62	14.86	6.56	0.87	0.44	1.46	2.33
pineal gland - adult, donor10196	10179-103C8	140.62	7.10	7.74	1.29	0.00	1.29	0.00	0.00	0.00
pineal gland, adult, donor10252	10160-103A7	192.47	10.66	5.92	1.18	0.00	2.96	0.59	0.00	0.00
pineal gland, adult, donor10258	10377-105G8	166.80	6.90	6.27	1.88	0.63	1.88	0.63	0.00	1.25
pituitary gland - adult, donor10196	10180-103C9	200.34	25.30	7.08	4.05	0.00	1.01	1.01	0.00	0.00
pituitary gland, adult, donor10252	10162-103A9	252.25	16.68	10.42	3.13	0.52	3.13	1.56	0.00	0.00
pituitary gland, adult, donor10258	10378-105G9	210.26	10.21	12.77	4.26	0.00	3.40	0.85	0.00	0.00
placenta, adult, pool1	10021-101D3	318.64	22.90	10.00	3.66	1.72	1.08	1.94	0.22	0.11
plasma cell leukemia cell line:ARH-77	10840-111E3	278.76	54.82	15.10	16.69	6.49	2.25	0.93	1.19	0.53
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	201.71	8.56	10.74	2.02	0.78	0.78	0.47	0.00	0.00
pons, adult, pool1	10033-101E6	159.83	10.16	12.14	4.48	1.72	1.72	5.34	0.09	0.86
postcentral gyrus, adult, pool1	10032-101E5	258.39	17.26	9.59	6.28	1.13	3.75	6.45	0.00	0.44
promyelocytes/myelocytes PMC, donor1	12132-128D8	612.78	46.01	117.12	18.82	8.37	2.09	0.00	0.00	4.18
promyelocytes/myelocytes PMC, donor2	12136-128E3	572.84	38.56	77.11	11.02	0.00	5.51	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	434.22	35.21	93.89	0.00	0.00	11.74	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	610.76	129.06	110.27	52.29	27.09	2.18	1.02	3.64	5.97
prostate cancer cell line:PC-3	10439-106E7	465.19	58.26	38.12	12.71	3.27	1.09	0.73	1.63	1.27
prostate, adult, pool1	10022-101D4	177.12	13.15	5.71	2.36	0.54	3.72	2.27	0.00	0.09
putamen, adult, donor10196	10176-103C5	156.04	10.39	6.85	3.07	2.83	1.89	4.96	0.00	0.47
putamen, adult, donor10252	10152-102I8	176.47	17.65	9.80	9.80	0.00	7.84	7.84	0.00	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	407.62	30.60	15.30	24.04	1.09	5.46	0.00	6.56	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	222.52	13.29	3.38	4.35	0.72	1.93	4.83	0.24	0.00
putamen, newborn, donor10223	10365-105F5	109.45	7.50	1.50	1.50	0.00	3.75	3.00	0.75	0.00
rectal cancer cell line:TT1TKB	10469-106I1	148.67	20.37	22.11	2.33	2.33	0.58	0.29	0.00	0.87
rectum, fetal, donor1	10067-101I4	147.45	6.95	16.69	0.00	0.00	0.00	2.78	0.00	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	524.48	35.40	34.77	11.87	2.12	0.64	0.00	1.06	0.42
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	137.52	11.60	6.21	2.90	1.66	0.41	0.41	0.00	0.00
retina, adult, pool1	10030-101E3	242.34	16.20	4.47	2.48	0.50	3.98	3.68	0.00	0.10
retinoblastoma cell line:Y79	10475-106I7	479.59	44.17	15.85	11.17	7.01	3.38	2.86	1.04	1.30
rhabdomyosarcoma cell line:KYM-1	10787-110H4	397.25	42.79	32.95	10.94	7.01	1.23	1.23	10.20	0.86
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	402.12	23.90	7.31	3.94	2.25	2.25	5.06	0.00	0.28
sacrococcigeal teratoma cell line:HTST	10695-109G2	165.21	12.13	12.13	2.27	0.76	0.00	0.00	0.00	0.76
salivary acinar cells, donor1	11771-123I7	232.26	44.83	54.71	9.06	2.59	0.97	0.49	1.29	1.13
salivary acinar cells, donor2	11772-123I8	287.49	38.41	48.05	5.51	0.96	0.55	0.96	0.28	0.55
salivary acinar cells, donor3	11773-123I9	97.32	14.57	21.85	1.32	1.99	0.00	0.66	0.66	0.66
salivary gland, adult, pool1	10093-102C3	508.47	29.17	39.46	3.43	0.57	1.72	1.72	0.00	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	240.29	29.68	50.42	9.95	1.01	0.08	0.00	1.60	1.26
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	222.06	30.21	62.18	7.52	2.47	0.12	0.24	1.53	1.41
seminal vesicle, adult	10201-103F3	199.46	13.76	8.99	4.23	0.00	0.00	1.59	0.00	0.00
serous adenocarcinoma cell line:JHOS-2	10639-108I9	186.08	48.34	35.95	12.63	3.40	2.19	0.49	0.24	0.97
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	257.17	14.59	9.31	4.78	1.01	1.26	0.50	0.00	0.50
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	481.70	32.11	30.11	13.05	0.00	0.00	0.00	0.00	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	196.11	17.86	5.78	3.09	0.54	0.27	0.40	0.00	0.00
signet ring carcinoma cell line:Kato III	10436-106E4	290.80	28.52	31.50	7.96	1.77	0.55	0.00	0.22	0.55
signet ring carcinoma cell line:NUGC-4	10483-107A6	312.76	47.48	36.90	10.32	2.32	1.42	0.39	1.81	0.77
skeletal muscle - soleus muscle, donor1	10282-104F3	321.33	17.73	22.70	2.13	0.00	0.71	2.84	0.00	0.71
skeletal muscle, adult, pool1	10023-101D5	346.74	30.94	21.59	3.60	1.80	5.64	4.44	0.24	0.12
skeletal muscle, fetal, donor1	10066-101I3	227.13	8.04	13.07	0.00	2.01	4.02	4.02	0.00	0.00
skin, adult, donor1	10074-102A2	196.77	6.79	27.14	6.79	0.00	0.00	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	261.33	20.20	25.25	3.16	1.89	1.89	0.63	0.00	1.26
small cell cervical cancer cell line:HCSC-1	10800-110I8	632.03	52.70	24.35	15.68	7.00	6.67	1.67	0.67	1.33
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	363.75	23.64	20.17	3.47	1.26	5.99	2.21	0.32	1.26
small cell lung carcinoma cell line:DMS 144	10841-111E4	414.02	35.66	22.74	9.44	3.08	0.96	0.96	0.96	2.12
small cell lung carcinoma cell line:LK-2	10541-107H1	490.53	53.90	41.54	10.22	6.26	2.64	0.66	1.81	1.32
small cell lung carcinoma cell line:NCI-H82	10842-111E5	608.66	40.86	13.19	22.84	11.10	3.38	0.97	0.48	0.32
small cell lung carcinoma cell line:WA-hT	10562-108A4	230.77	10.24	29.64	2.40	1.96	3.92	3.70	1.96	0.22
small intestine, adult, pool1	10024-101D6	269.82	20.42	21.38	5.37	0.96	2.99	1.07	0.12	0.24
small intestine, fetal, donor1	10064-101I1	173.22	9.83	17.44	1.23	0.98	1.72	1.23	0.25	0.49
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	311.33	20.52	30.77	4.62	1.54	0.00	0.51	0.00	1.03
smooth muscle, adult, pool1	10048-101G3	163.60	11.89	7.75	0.78	1.03	2.84	3.62	0.00	0.26
somatostatinoma cell line:QGP-1	10781-110G7	372.82	19.30	74.51	2.68	1.07	0.00	0.00	0.54	1.61
spinal cord - adult, donor10196	10181-103D1	75.93	3.67	4.13	0.46	0.23	1.84	2.98	0.23	0.00
spinal cord, adult, donor10252	10159-103A6	116.70	8.28	5.91	0.79	0.00	1.58	4.73	0.00	0.00
spinal cord, adult, donor10258	10369-105F9	164.65	5.53	4.84	2.77	0.00	4.15	6.92	0.00	0.00
spinal cord, fetal, donor1	10056-101H2	236.62	15.25	6.10	3.66	1.83	3.05	9.76	0.00	0.00
spinal cord, newborn, donor10223	10359-105E8	245.22	20.66	11.48	4.13	0.46	4.59	2.76	0.00	0.00
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	394.74	42.72	54.51	6.57	1.79	0.45	0.75	0.75	1.19
spleen, adult, pool1	10025-101D7	263.44	23.57	25.88	5.95	3.08	4.85	4.19	0.44	0.00
spleen, fetal, pool1	10044-101F8	271.97	27.17	19.55	4.69	1.59	4.21	4.13	0.64	0.00
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	412.60	73.91	62.31	26.71	6.00	10.14	6.73	5.28	0.52
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	266.02	41.96	46.14	9.49	3.80	0.57	0.19	1.14	2.09
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	425.98	44.38	68.14	13.28	4.89	2.80	0.70	0.00	1.40
squamous cell carcinoma cell line:T3M-5	10616-108G4	204.07	41.44	44.18	8.60	2.74	0.00	0.00	1.17	1.56
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	575.51	85.21	73.05	19.14	4.39	2.03	0.68	2.03	1.35
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	296.52	37.70	17.79	13.13	2.12	2.12	0.42	0.85	0.00
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	800.87	92.23	86.73	27.50	8.04	2.12	1.27	2.12	1.69
stomach, fetal, donor1	10062-101H8	252.04	13.88	46.99	1.07	1.07	0.00	0.00	0.00	1.07
submaxillary gland, adult	10202-103F4	235.28	9.68	16.52	0.57	1.14	2.28	0.57	0.00	0.57
substantia nigra - adult, donor10196	10178-103C7	379.92	0.00	0.00	0.00	0.00	0.00	54.27	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	144.77	10.80	5.61	1.04	1.66	3.74	7.69	0.00	0.00
substantia nigra, adult, donor10258	10371-105G2	215.18	14.48	6.21	4.66	0.00	3.62	4.66	0.52	0.52
substantia nigra, newborn, donor10223	10358-105E7	166.05	5.65	5.65	2.83	0.00	0.00	0.71	0.00	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	466.55	55.48	45.17	18.11	8.48	1.15	2.06	1.38	2.06
temporal lobe, adult, pool1	10031-101E4	267.03	20.77	12.12	6.95	1.78	2.29	7.29	0.00	0.59
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	262.83	7.83	4.99	0.71	0.00	2.85	1.42	0.00	0.71
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	372.29	7.91	3.96	3.52	0.44	3.96	1.76	0.00	0.88
tenocyte, donor1	11763-123H8	571.13	51.67	72.61	12.57	6.28	0.35	1.75	0.00	1.40
tenocyte, donor2	11765-123I1	302.53	22.13	38.15	3.05	0.38	1.14	1.14	0.00	1.91
tenocyte, donor3	11768-123I4	613.08	71.17	84.51	15.20	4.45	1.48	2.59	0.00	2.97
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	840.62	86.00	26.85	26.34	16.66	2.38	1.70	9.52	2.38
teratocarcinoma cell line:NCR-G1	10798-110I6	290.42	40.39	14.64	6.17	9.25	2.31	2.00	1.54	0.62
teratocarcinoma cell line:PA-1	10807-111A6	469.12	56.88	23.56	20.77	12.86	2.48	1.24	3.10	0.77
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	257.20	42.15	33.77	15.87	12.19	2.29	1.90	1.90	1.27
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	197.03	25.72	8.70	11.35	8.70	2.65	2.65	0.00	0.38
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	179.52	20.18	17.67	4.91	5.34	1.64	0.98	0.55	0.76
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	288.90	42.67	2.93	21.50	3.91	4.56	1.63	0.98	0.33
testis, adult, pool1	10026-101D8	244.49	21.05	56.59	5.69	3.11	5.69	6.23	3.54	1.07
testis, adult, pool2	10096-102C6	313.50	21.65	108.71	9.02	2.26	9.47	5.86	15.34	4.06
thalamus - adult, donor10196	10168-103B6	109.29	8.83	7.73	1.10	1.10	2.21	4.42	0.00	1.10
thalamus, adult, donor10252	10154-103A1	142.84	10.78	4.06	1.56	1.25	3.91	5.00	0.00	0.00
thalamus, adult, donor10258, tech_rep1	10370-105G1	361.81	12.32	9.24	4.62	0.00	9.24	3.08	0.00	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	85.97	5.93	8.56	1.98	0.16	1.15	3.46	0.00	0.49
thalamus, newborn, donor10223	10366-105F6	158.21	8.63	10.36	3.45	0.00	2.30	2.30	0.00	0.00
throat, adult	10209-103G2	227.70	19.97	12.48	5.99	1.25	2.75	3.00	0.50	0.25
throat, fetal, donor1	10061-101H7	223.65	10.06	8.53	0.61	1.83	2.44	3.05	0.00	0.00
thymic carcinoma cell line:Ty-82	10803-111A2	396.87	34.38	50.68	14.11	3.58	0.79	0.20	2.78	2.38
thymus, adult, pool1	10027-101D9	341.89	40.46	25.25	13.62	9.15	5.17	3.68	0.40	0.30
thymus, fetal, pool1	10043-101F7	235.55	25.87	12.26	4.78	4.47	3.53	2.49	0.42	0.52
thyroid carcinoma cell line:KHM-5M	10776-110G2	391.44	52.52	41.88	16.49	2.93	1.06	0.53	1.73	1.06
thyroid carcinoma cell line:TCO-1	10783-110G9	602.21	108.40	108.96	37.44	28.36	3.21	1.40	1.40	1.96
thyroid, adult, pool1	10028-101E1	294.50	27.25	9.52	4.11	0.84	4.85	4.29	0.09	0.19
thyroid, fetal, donor1	10060-101H6	203.55	10.02	5.27	0.79	0.26	0.26	2.90	0.00	0.26
tongue epidermis (fungiform papillae), donor1	10288-104F9	344.92	15.40	55.43	0.00	0.00	0.00	0.00	0.00	3.08
tongue, adult	10203-103F5	362.36	64.42	31.40	19.07	2.56	3.95	2.79	0.47	0.47
tongue, fetal, donor1	10059-101H5	250.25	17.34	18.52	2.76	2.76	6.31	5.52	0.00	0.00
tonsil, adult, pool1	10047-101G2	379.06	53.09	47.38	11.42	5.41	5.11	4.41	0.60	0.80
trachea, adult, pool1	10029-101E2	306.83	41.14	26.18	9.16	2.37	1.80	1.96	0.41	0.65
trachea, fetal, donor1	10058-101H4	230.43	15.00	22.70	2.69	0.00	0.38	2.69	0.00	0.38
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	406.00	57.75	42.51	17.71	2.83	0.35	0.35	0.71	0.71
transitional-cell carcinoma cell line:5637	10418-106C4	555.01	66.77	43.06	16.92	3.34	1.82	2.03	2.53	0.61
transitional-cell carcinoma cell line:JMSU1	10492-107B6	234.56	34.63	38.39	13.48	5.01	1.72	0.94	1.72	1.25
tridermal teratoma cell line:HGRT	10694-109G1	192.16	28.54	45.66	5.71	3.81	0.00	0.00	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	201.72	17.18	32.68	4.06	1.69	1.02	0.25	0.59	0.85
umbilical cord, fetal, donor1	10057-101H3	246.21	10.43	27.12	4.17	0.00	6.26	2.09	0.00	0.00
uterus, adult, pool1	10100-102D1	277.27	20.13	8.53	2.39	1.02	3.07	4.78	0.34	0.17
uterus, fetal, donor1	10055-101H1	235.49	15.87	14.85	2.05	2.05	1.54	1.54	0.00	0.51
vagina, adult	10204-103F6	105.33	5.17	3.23	0.00	0.65	0.65	0.00	0.00	0.00
vein, adult	10191-103E2	194.21	15.56	10.52	2.41	0.66	3.29	2.63	0.22	0.00
xeroderma pigentosum b cell line:XPL 17	10563-108A5	443.28	81.18	36.58	21.63	7.74	2.94	2.94	2.40	1.07